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Pathogenic mutations in A-type nuclear lamins cause dilated cardiomyopathy, which is postulated to 22 
result from dysregulated gene expression due to changes in chromatin organization into active and 23 
inactive compartments. To test this, we performed genome-wide chromosome conformation analyses 24 
(Hi-C) in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) with a 25 
haploinsufficient mutation for lamin A/C. Compared to gene-corrected cells, mutant hiPSC-CMs have 26 
marked electrophysiological and contractile alterations, with modest gene expression changes. While 27 
large-scale changes in chromosomal topology are evident, differences in chromatin 28 
compartmentalization are limited to a few hotspots that escape inactivation during cardiogenesis. These 29 
regions exhibit upregulation of multiple non-cardiac genes including CACNA1A, encoding for neuronal 30 
P/Q-type calcium channels. Pharmacological inhibition of the resulting current partially mitigates the 31 
electrical alterations. On the other hand, A/B compartment changes do not explain most gene expression 32 
alterations in mutant hiPSC-CMs. We conclude that global errors in chromosomal compartmentation are 33 




Bertero et al. observe that lamin A/C haploinsufficiency in human cardiomyocytes markedly alters 38 
electrophysiology, contractility, gene expression, and chromosomal topology. Contrary to expectations, 39 
however, changes in chromatin compartments involve just few regions, and most dysregulated genes lie 40 
outside these hotspots. 41 
 42 
Condensed title 43 
 44 
Genomic effects of lamin A/C haploinsufficiency  45 
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Chromatin organization in the three-dimensional space has emerged as a key layer of mammalian gene 48 
expression control. The development of powerful technologies to map chromatin architecture, in 49 
particular genome-wide chromosome conformation capture (Hi-C; Lieberman-Aiden et al., 2009), has 50 
revealed that such 3D structure is complex, non-random, and hierarchical (Yu and Ren, 2017). Short- 51 
and long-range intra-chromosomal (cis) DNA interactions are generally constrained within topologically 52 
associating domains (TADs; Dixon et al., 2012; Nora et al., 2012; Sexton et al., 2012). TADs tend to 53 
interact based on their epigenetic status and transcriptional activity, thus dividing chromosomes into two 54 
types of large-scale compartments generally called active and inactive (A and B, respectively; Simonis 55 
et al., 2006; Lieberman-Aiden et al., 2009; Rao et al., 2014). Inter-chromosomal (trans) interactions 56 
predominantly involve the A compartment and are generally more limited, as chromosomes occupy 57 
distinct nuclear territories (Bolzer et al., 2005; Branco and Pombo, 2006; Kalhor et al., 2012). 58 
 59 
Moving beyond the third dimension, there has been growing interest in understanding the functional 60 
changes in chromatin organization during development and in disease (Dekker et al., 2017). An emerging 61 
body of work has shown that TADs are largely invariant across cell types (Dixon et al., 2012, 2015; Fraser 62 
et al., 2015; Won et al., 2016; Schmitt et al., 2016; Fields et al., 2017). On the other hand, these same 63 
studies have established that pluripotent stem cell differentiation leads to a substantial degree of A/B 64 
compartment reorganization (e.g. ~20% of the genome), and that this is associated with important 65 
developmental changes in gene expression. Nevertheless, the precise mechanisms that regulate 66 
chromatin compartmentalization dynamics during development are still poorly understood (Adriaens et 67 
al., 2018). In the context of disease, disruption of TADs due to copy number variations or point mutations 68 
was shown to lead to congenital developmental disorders and cancers (Lupiáñez et al., 2015; Katainen 69 
et al., 2015; Redin et al., 2017; Sun et al., 2018). In contrast, whether dysregulation of A/B compartments 70 
plays a role in functional changes of gene expression leading to human disease is still unclear (Krumm 71 
and Duan, 2018). 72 
 73 
The nuclear lamina has been proposed as a regulator of chromatin compartmentalization in development 74 
and disease (Buchwalter et al., 2018). The lamina lies along the inner nuclear membrane and is a 75 
complex mesh of nuclear intermediate filaments (A- and B-type lamins) and lamin-associated proteins. 76 
This structure provides key mechanical support to the nucleus, and is an important hub for the control of 77 
intracellular signaling (Dobrzynska et al., 2016). Moreover, the nuclear lamina interacts with large 78 
chromatin regions, aptly named lamin-associated domains (LADs; van Steensel and Belmont, 2017), 79 
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which show heterochromatic features such as low gene density, enrichment for repressive histone marks, 80 
and poor transcriptional activity (Guelen et al., 2008). Several studies have established that such 81 
peripherally-located LADs strongly correlate with the B compartment, while the A compartment is 82 
predominantly in the nuclear interior (Kind et al., 2015; Stevens et al., 2017; Luperchio et al., 2017; Zheng 83 
et al., 2018). Both lamins and lamin-associated proteins, such as LBR (lamin B receptor), can directly 84 
interact with chromatin (Yuan et al., 1991; Taniura et al., 1995; Ye and Worman, 1994, 1996). Based on 85 
this and on the results of loss-of-function studies it has been proposed that the nuclear lamina tethers 86 
LADs at the nuclear periphery (Solovei et al., 2013; Harr et al., 2015; Luperchio et al., 2017). However, 87 
the precise role of A- and B-type lamins in chromatin compartmentalization is still being debated 88 
(Amendola and van Steensel, 2015; Zheng et al., 2015, 2018; Adriaens et al., 2018). 89 
 90 
Elucidating the function of A-type lamins (lamin A and lamin C, which result from alternative splicing of 91 
the LMNA gene) is particularly important not only from a cell and developmental biology perspective, but 92 
also because of their involvement in human disease. LMNA mutations lead to a wide spectrum of 93 
conditions collectively referred to as laminopathies (Capell and Collins, 2006). Notably, nearly 80% of all 94 
reported LMNA mutations lead to isolated striated muscle disease, with another 10% leading to 95 
overlapping phenotypes that also affect striated muscles (Bertrand et al., 2011). The majority of patients 96 
with striated muscle laminopathies develop dilated cardiomyopathy (DCM), with variable skeletal muscle 97 
manifestations (Captur et al., 2018). Mutations in LMNA are generally considered the second-most most 98 
common cause of familial DCM, depending on the ethnicity of the population (Akinrinade et al., 2015; 99 
Haas et al., 2015; Tobita et al., 2018). Compared to other types of DCM, LMNA-DCM is quite atypical as 100 
it is characterized by early onset of life-threatening cardiac electrical abnormalities such as severe 101 
conduction system disease and/or atrial and ventricular arrhythmias (Van Rijsingen et al., 2012; 102 
Hasselberg et al., 2018; Kumar et al., 2016). Another peculiar aspect of LMNA-DCM is that not all patients 103 
go on to develop left ventricular dilatation and reduced contractile function, which are typical hallmarks 104 
of DCM (Van Berlo et al., 2005; Kumar et al., 2016; Tobita et al., 2018). Nevertheless, patients with 105 
LMNA-DCM are poorly responsive to medical treatments and show minimal beneficial left ventricular 106 
reverse remodeling (Tobita et al., 2018). This may be explained by the higher incidence of cardiac fibrosis 107 
in LMNA-DCM patients (van Tintelen et al., 2007b; Fontana et al., 2013; Tobita et al., 2018). Overall, 108 
LMNA-DCM (which throughout the rest of the manuscript we will refer to as “cardiac laminopathy”) is a 109 
more severe disease compared to other genetic DCM, with young onset, high penetrance, poor 110 
prognosis, and frequent need for heart transplantation as the only current available therapy (Hasselberg 111 
et al., 2018; Tobita et al., 2018). 112 
 113 
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Over the nearly 20 years since the first report linking mutations in LMNA to human disease (Bonne et al., 114 
1999), three central non-mutually exclusive mechanisms have been hypothesized to underpin the 115 
pathogenesis of cardiac laminopathy: (1) impaired nuclear mechanoresistance via the nucleo-116 
cytoplasmic network, or “mechanical hypothesis”; (2) alteration of lamin A/C-controlled intracellular 117 
signaling pathways, or “signaling hypothesis”; and (3) dysregulation of heterochromatin organization 118 
leading to gene expression alterations, or “chromatin hypothesis” (Worman and Courvalin, 2004; Cattin 119 
et al., 2013). While evidence supporting the first two hypotheses has accumulated over the years, and 120 
therapies targeting intracellular signaling alterations are being pre-clinically developed (Cattin et al., 2013; 121 
Captur et al., 2018), the possible involvement of chromatin dysregulation in cardiac laminopathy is still 122 
far from established (Adriaens et al., 2018). Indeed, while there have been reports of changes in the 123 
nuclear positioning of selected loci in patients with cardiac laminopathy (Meaburn et al., 2007; Mewborn 124 
et al., 2010), the functional consequences of such alterations on the disease pathogenesis are unclear. 125 
Moreover, these studies have relied on fibroblasts instead of cardiomyocytes, the primary cell type 126 
involved in cardiac laminopathy. Most importantly, to the best of our knowledge the 3D chromatin 127 
organization changes associated with cardiac laminopathy have not yet, been tested at a genome-wide 128 
level. 129 
 130 
To address these limitations, we performed genome-wide chromosome conformation capture (Hi-C) and 131 
gene expression (RNA-seq) analyses to examine the changes in 3D chromatin architecture induced by 132 
a haploinsufficient LMNA mutation in cardiomyocytes derived from human induced pluripotent stem cells 133 
(hiPSC-CMs). We hypothesized that decreased expression of A-type lamins would lead to broad 134 
functional alterations in A/B compartmentalization leading to aberrant gene expression. We observed 135 
that mutant hiPSC-CMs show marked alterations in their electrophysiological and contractile phenotypes, 136 
broad dysregulation of gene expression, and alterations in large-scale chromosomal topology 137 
(strengthened separation between chromosome territories and between chromatin compartments). 138 
However, functional changes in A/B compartmentalization are limited to a few genomic hotspots that 139 
normally transition from the A to B compartment during cardiogenesis, but remain in A in lamin A/C 140 
haploinsufficient hiPSC-CMs. These hotspots exhibit upregulation of multiple non-cardiac genes, 141 
including the neuronal gene CACNA1A, which encodes for P/Q-type calcium channels. Of note, however, 142 
changes in A/B compartments do not explain the majority of gene expression changes, including the 143 
upregulation of the cardiac gene CACNA1C, which encodes for the L-type calcium channel. 144 
Pharmacological inhibition of P/Q-type calcium currents partially mitigates the field potential duration 145 
elongation observed in mutant hiPSC-CMs, while inhibition of L-type calcium currents has a more 146 
powerful effect. We conclude that, while LMNA haploinsufficient mutations functionally affect selected 147 
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aspects of 3D chromatin organization in human cardiomyocytes, altered A/B compartmentalization does 148 





Generation of an in vitro model of cardiac lamin A/C haploinsufficiency 154 
To investigate the role of chromatin dynamics in cardiac laminopathy, we took advantage of hiPSCs 155 
bearing a heterozygous nonsense mutation in LMNA predicted to cause premature truncation of both 156 
lamin A and lamin C splicing isoforms (c.672C>T, resulting in p.Arg225*, which we will refer to as R225X; 157 
Fig. 1A). This hiPSC line was previously derived from a 56-year-old male patient who developed severe 158 
cardiac conduction disease evolving into heart failure, a condition that segregated within the family with 159 
autosomal dominant inheritance of the R225X mutation (Siu et al., 2012). This same mutation has been 160 
reported in multiple other cohorts with similar symptoms (van Tintelen et al., 2007a; Saga et al., 2009; 161 
Jakobs et al., 2001), establishing it as a bona fide genetic cause of cardiac laminopathy. 162 
 163 
It is well established that variability among hiPSC lines can profoundly influence both molecular and 164 
cellular phenotypes (Ortmann and Vallier, 2017), which is particularly evident when assessing the 165 
complex electrophysiology and contractile properties of hiPSC-CMs (Sala et al., 2017). Thus, we decided 166 
to generate isogenic control hiPSCs by correcting the R225X mutation back to the wild-type allele, a 167 
strategy currently considered the gold standard to determine the association between genotype and 168 
phenotype in hiPSC-CMs (Bellin et al., 2013; Kodo et al., 2016; Mosqueira et al., 2018). By leveraging 169 
existing methods (Yusa, 2013), we designed a two-step scarless gene editing strategy relying on 170 
CRISPR/Cas9-facilitated homologous recombination of a targeting vector containing the wild-type allele 171 
in the 3’ homology arm, and an excisable piggyBac drug resistance cassette (Fig. S1A-B). To control for 172 
the potential variability between hiPSC sublines, we obtained two isogenic control hiPSCs using distinct 173 
sgRNA sequences (Fig. 1B and S1C-D). The resulting hiPSCs, which we will refer to as Corr.1 and Corr.2 174 
(short for Corrected 1 and Corrected 2) were karyotypically normal (Fig. S1E). 175 
 176 
Lamin A/C is expressed at very low levels in human pluripotent stem cells, and is upregulated during 177 
differentiation (Constantinescu et al., 2006; Liu et al., 2011). Given that hiPSC-CMs are quite immature 178 
(Yang et al., 2014), we sought to first confirm whether hiPSC-CMs express substantial levels of lamin 179 
A/C. Further, we tested the consequence of the R225X mutation on lamin A/C expression at the transcript 180 
and protein level. For this, we differentiated hiPSCs into hiPSC-CMs using an established protocol based 181 
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on the temporal modulation of WNT signaling using small molecules (Burridge et al., 2014; Fields et al., 182 
2017; Fig. 1C). Both mutant and corrected hiPSCs could be differentiated with high efficiency, as 183 
measured by flow-cytometry for TNNT2 (Fig. 1D, Video S1, and Video S2; 91.6% ± 3.2%, 94.4% ± 2.5%, 184 
and 91.3% ± 3.1% for Mutant, Corr.1, and Corr.2, respectively; average ± SEM of n = 4 independent 185 
differentiations). Western blot and quantitative reverse transcription PCR (RT-qPCR) confirmed that all 186 
hiPSC lines underwent the expected developmental progression through mesoderm and cardiac 187 
progenitors before reaching a cardiomyocyte phenotype (Fig. 1F and S2A). Lamin A/C was upregulated 188 
specifically in hiPSC-CMs, and mutant lines showed significantly reduced levels of both mRNA and 189 
protein compared to both corrected controls (Fig. 1E-G). Of note, no detectable protein truncation was 190 
detected by western blot (Fig. S2B), and lamin A/C expression in mutant hiPSC-CMs also proved to be 191 
reduced when compared to cardiomyocytes generated from an unrelated hiPSC line derived from a 192 
healthy individual (Fig. S2C). Finally, other minor LMNA isoforms were undetectable or nearly 193 
undetectable by RT-qPCR in both control and mutant hiPSC-CMs, excluding possible compensatory 194 
mechanisms (data not shown). These gene expression data agree with earlier findings from analysis of 195 
skin fibroblasts bearing the R225X heterozygous mutation (Siu et al., 2012), and indicate that such 196 
premature nonsense mutation leads to lamin A/C haploinsufficiency presumably due to nonsense-197 
mediated decay of both the lamin A and lamin C transcripts. Collectively, we established a robust in vitro 198 
model to study cardiac laminopathy due to lamin A/C haploinsufficiency in developing cardiomyocytes. 199 
 200 
Lamin A/C haploinsufficiency alters hiPSC-CM automaticity and prolongs membrane 201 
depolarization 202 
Before exploring the effect of lamin A/C haploinsufficiency on chromatin dynamics, we wished to confirm 203 
a phenotypic effect on cardiac physiology in developing hiPSC-CMs. Indeed, cardiac laminopathy is a 204 
disease that manifests in the third to fourth decade of life, and previous efforts to model the disease in 205 
immature cardiomyocytes have been focused on studying nuclear dysmorphology, cellular senescence, 206 
and susceptibility to apoptosis (Siu et al., 2012; Lee et al., 2017). Since electrical abnormalities are the 207 
primary and most characteristic manifestations of cardiac laminopathy (Van Rijsingen et al., 2012; 208 
Hasselberg et al., 2018; Kumar et al., 2016), we began by assessing the electrophysiological properties 209 
of mutant hiPSC-CMs. For this, we first used multi-electrode arrays (MEAs) to measure the extracellular 210 
electric field potential elicited by spontaneously contracting monolayers of hiPSC-CMs at day 30 of 211 
differentiation. Mutant cells showed a number of alterations compared to both corrected controls. Most 212 
notably, the beat rate proved highly erratic and prone to prolonged pauses (Fig. 2A). Moreover, even 213 
when the analysis was focused on the periods showing the highest consistency, the beat rate was still 214 
more irregular and reduced (Fig. 2B). The amplitude of field potential changes was elevated more than 215 
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2-fold compared to controls, which is indicative of stronger depolarizing ion currents (Fig. 2B). Along the 216 
same lines, the field potential duration (FPD), which indicates the interval between depolarization and 217 
repolarization, was prolonged by ~60% (Fig. 2B). This finding held true even when the FPD was corrected 218 
for the beat period (FPDc; Fig. 2B), an established way to robustly compare the FPD across multiple 219 
conditions (Rast et al., 2016; Asakura et al., 2015). Of note, despite all of these alterations, the conduction 220 
velocity across the monolayer was not affected (Fig. 2B), indicating that intercellullar electrical coupling 221 
was preserved in mutant cells. 222 
 223 
To further characterize the electrophysiological properties of mutant hiPSC-CMs, we performed whole-224 
cell patch clamp recordings of voltage changes occurring during action potentials firing in individual 225 
cardiomyocytes. To promote a mature phenotype and enhance cell viability during the invasive patch 226 
procedure, we cultured hiPSC-CMs onto biomimetic anisotropic nanopatterns (Carson et al., 2016; 227 
Macadangdang et al., 2015). While a number of parameters were unaffected in mutant cells (such as 228 
maximum diastolic potential, action potential amplitude, mean diastolic potential, and repolarization 229 
amplitude; Fig. 2D and data not shown), the action potential duration and exponential time constant for 230 
the action potential decay were increased (Fig. 2C-D). This observation provided a cell-autonomous 231 
explanation for the increased FPDc in cell monolayers, and indicated that this phenotype is maintained 232 
in maturing hiPSC-CMs. 233 
 234 
Finally, we measured the effects of excitation abnormalities in mutant cells on their intracellular calcium 235 
dynamics using the fluorescent calcium reporter Fluo-4. Electrically-paced mutant cell monolayers 236 
showed stronger and longer calcium peaks (Fig. 2E-F, Video S3, and Video S4), in agreement with MEA 237 
and patch clamp data. Overall, these findings indicate that lamin A/C haploinsufficiency in developing 238 
cardiomyocytes leads to altered automaticity and prolonged membrane depolarization leading to more 239 
robust calcium transients. 240 
 241 
Systolic hyperfunction and diastolic dysfunction in lamin A/C haploinsufficient hiPSC-CMs 242 
Since changes in intracellular calcium concentrations are the primary determinant of hiPSC-CM 243 
contractility, we examined the effect of lamin A/C haploinsufficiency on this process. First, we performed 244 
correlation-based contraction quantification (CCQ) analyses to measure the cellular displacement 245 
associated with cardiac contraction in electrically-paced hiPSC-CM monolayers (Macadangdang et al., 246 
2015). Mutant cells showed ~50% stronger contractions and a delayed relaxation time (Fig. 3A-B, Video 247 
S5, and Video S6), consistent with their stronger and prolonged calcium fluxes.  248 
 249 
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To validate these findings in a more physiologically-relevant model, we performed biomechanical 250 
assessments of contractility in electrically-paced three-dimensional engineered heart tissues (3D-EHTs), 251 
an established model to promote cardiac maturation by providing topological, mechanical, and 252 
multicellular cues (Leonard et al., 2018; Ruan et al., 2016). In agreement with observations in 2D 253 
monolayers, mutant 3D-EHTs showed ~2-fold stronger and prolonged contractions with a markedly 254 
impaired relaxation kinetic (Fig. 3C-D, Video S7, and Video S8). Collectively, we concluded that lamin 255 
A/C haploinsufficiency leads to systolic hyperfunction and diastolic dysfunction in both early and maturing 256 
cardiomyocytes. 257 
 258 
Lamin A/C haploinsufficiency causes dysregulation of specific ion channel genes and broad gene 259 
expression changes 260 
To explore the molecular mechanisms that might explain the electrophysiological and contractile 261 
phenotypes observed in lamin A/C haploinsufficient hiPSC-CMs, we first monitored the expression of the 262 
genes encoding key ion-handling proteins involved in the generation of action potentials and in excitation-263 
contraction coupling (Amin et al., 2010; Eisner et al., 2017). RT-qPCR analyses excluded a dysregulation 264 
of a large number of such genes, including the voltage-gated sodium channel SCN5A, the sodium-265 
calcium exchanger NCX, and the sarcoplasmic calcium ATPase ATP2A2 (also known as SERCA2a; Fig. 266 
S2D). On the other hand, mutant cells showed a significant upregulation of CACNA1C, and 267 
downregulation of KCNQ1 (Fig. 4A). CACNA1C encodes for the pore-forming subunit of L-type calcium 268 
channels which mediate ICa,L, the main source of inward depolarizing current during phase 2 (plateau) of 269 
the action potential (Bodi et al., 2005). On the other hand, IKS, the outward potassium current resulting 270 
from the potassium channel encoded by KCNQ1, antagonizes ICa,L in phase 2 by initiating membrane 271 
repolarization (Peroz et al., 2008). Thus, the combined effects of CACNA1C upregulation and KCNQ1 272 
downregulation could explain the prolonged membrane depolarization observed in mutant cells. 273 
 274 
We then expanded these gene expression analyses genome-wide by performing RNA sequencing of 275 
hiPSC-CM monolayers at day 14 of differentiation on biological triplicates (RNA-seq; Table S1). While 276 
cells from the two corrected control lines clustered closely and showed remarkably similar gene 277 
expression profiles (29 upregulated and 71 downregulated genes between Corr.1 and Corr.2; fold-278 
change > 2 and q-value < 0.05; Fig. 4B and Table S1), mutant cells clustered separately due to 279 
substantial gene up- and downregulation (Fig. 4B-C and Table S1). To increase the robustness of our 280 
subsequent analyses, we only considered genes as dysregulated if they had significant expression 281 
changes in mutant hiPSC-CMs versus both corrected controls (185 upregulated and 140 downregulated; 282 
Fig. 4C and Table S1). Ontology and pathway enrichment analyses on these gene lists revealed that 283 
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upregulation in mutant cells was significantly associated with: (1) focal adhesion, MAPK, and TGFß 284 
pathways; (2) transcriptional activation, positive regulation of cardiac differentiation, and inhibition of 285 
apoptosis; (3) non-cardiac lineage expression (such as fibroblast and smooth muscle; Fig. 4D and Table 286 
S2). Notable examples of genes within these categories include: (1) PDGFA, EGF, and GDF7; (2) TBX3, 287 
TBX20, and HAND1, (3) CTGF/CCN2, MYH9, and ACTA2. In contrast, downregulated genes were 288 
enriched in cardiac transcripts and factors involved in cardiomyopathy and PI3K pathways, such as 289 
TNNT3, TNNI3, SGCA, NGFR, and PDGFD (Fig. 4D and Table S2). We also compared these RNA-seq 290 
data with those we recently obtained from human embryonic stem cells (hESCs) profiled at different time 291 
points of cardiac differentiation (Fields et al., 2017). Linear dimensionality reduction by principal 292 
component analysis showed that both mutant and corrected hiPSC-CMs clustered closely to hESC-CMs 293 
(Fig. 4E). This indicated that despite dysregulation of >300 genes, mutant hiPSC-CMs were not globally 294 
developmentally delayed from a transcriptional standpoint. These data suggest that lamin A/C 295 
haploinsufficiency in developing hiPSC-CMs leads to dysregulation of multiple signaling pathways, in 296 
agreement with earlier findings from mouse models (Arimura et al., 2005; Muchir et al., 2007; Ramos et 297 
al., 2012; Choi et al., 2012). Further, it prevents efficient silencing of some cardiac developmental 298 
regulators and alternative lineage genes, while specific cardiac genes are not fully activated. 299 
 300 
Lamin A/C haploinsufficiency strengthens the separation between chromosome territories and 301 
between chromatin compartments 302 
Having established that lamin A/C haploinsufficiency results in marked changes in both gene expression 303 
and cellular physiology in developing hiPSC-CMs, we tested whether some of these phenotypes could 304 
be explained by changes in chromatin topology. In order to explore this aspect at a genome-wide level, 305 
we took advantage of in situ DNase Hi-C to capture all pairwise interactions between any two genomic 306 
regions (Ramani et al., 2016). We analyzed two independent batches of hiPSC-CMs at day 14 of 307 
differentiation from the mutant and two corrected lines, and we confirmed that the resulting Hi-C data 308 
were of high quality and reproducible across biological replicates, with samples clustering separately 309 
based on their genotype (Fig. 5A and Table S3). We then began exploring the global properties of 310 
chromatin topology and noticed that mutant cells showed an increased ratio of genomic interactions with 311 
the same chromosome (in cis) over those involving different chromosomes (in trans; Fig. 5B). Moreover, 312 
trans interactions were distributed differently: while all hiPSC-CMs showed the expected pattern of 313 
preferential self-association between small, gene-rich chromosomes (especially chromosomes 16, 17, 314 
19, 20, and 22) and between large, gene-poor chromosomes (such as chromosomes 1 to 8; Fig. S3A; 315 
Lieberman-Aiden et al., 2009), this property was even more striking in mutant cells (Fig. 5C). On the 316 
contrary, interactions between small and large chromosomes were less frequent (Fig. 5C). Thus, lamin 317 
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A/C haploinsufficiency reinforces the separation between chromosome territories and their segregation 318 
based on size and gene density. 319 
 320 
We then analyzed the separation of chromatin domains into the active (A) or inactive (B) compartment. 321 
For this, we computed the first principal component (PC1) from the contact matrix using bins of 500 Kb 322 
(Table S4), a well-established method to determine chromatin compartments based on their preferential 323 
association (Imakaev et al., 2012; Lieberman-Aiden et al., 2009). In agreement with our previous 324 
observations in hESC-CMs (Fields et al., 2017), trans interactions between chromatin domains favored 325 
A-A compartments, and this was not affected by lamin A/C haploinsufficiency (Fig. S3B). In cis, mutant 326 
cells showed stronger interactions between A-A compartments (Fig. 5D and Fig. S3B), particularly due 327 
to increased short-range contacts within 0.5-1 Mb (Fig. 5E). In contrast, interactions between heterotypic 328 
regions (A-B) were reduced in mutant cells (Fig. 5D and Fig. S3B), particularly for long-range contacts 329 
>10 Mb (Fig. 5E). Collectively, lamin A/C haploinsufficiency reinforces the separation between the active 330 
and inactive chromatin compartments. 331 
 332 
Incomplete transitions from the active to inactive chromatin compartment in lamin A/C 333 
haploinsufficient hiPSC-CMs 334 
To assess the effect of lamin A/C haploinsufficiency on chromatin compartmentalization, we identified 335 
genomic bins with significantly different A/B compartment scores and switching from active to inactive or 336 
vice versa between at least two conditions (Table S4). We noticed that the vast majority of compartment 337 
transitions were observed for mutant hiPSC-CMs versus each corrected control (Fig. 6A), and that B to 338 
A inversions were more common than A to B ones (42 and 27, respectively; Table S4). We observed 339 
that, 63% of A to B transitions in mutant cells involved the X chromosome, while B to A changes showed 340 
a notable concentration on chromosome 19 but were otherwise evenly spread across 13 additional 341 
chromosomes (Fig. 6B, Fig. S4A, and Table S4). Overall, compartment changes involved approximately 342 
1.2% of the genome, indicating that chromatin compartment dysregulation in mutant cells is not 343 
widespread but is actually highly restricted. 344 
 345 
To gain insight into the relationship between dysregulated regions and normal chromatin compartment 346 
dynamics during cardiomyocyte differentiation, we integrated Hi-C data from mutant and corrected 347 
hiPSC-CMs with those we previously generated at different time points throughout hESC-CM 348 
differentiation (Fields et al., 2017). Linear dimensionality reduction of A/B compartment scores for all 349 
samples confirmed that mutant hiPSC-CMs cluster separately from both corrected controls (Fig. 6C). 350 
Moreover, this analysis revealed that based on the first principal component (which explained 39% of the 351 
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variance and ordered hESC samples based on their developmental progression), mutant cells were 352 
mildly developmentally delayed from a chromatin compartmentalization standpoint (Fig. 6C). Accordingly, 353 
we observed a strong and significant enrichment for domains that normally transition from A to B during 354 
cardiac differentiation but remain in A in mutant cells (Fig. 6D). Notable examples of such behavior 355 
involved two 0.5 and 2.5 Mb-long portions of chromosome 19 (corresponding to 19p13.13 and 19q13.33, 356 
respectively), and a 1 Mb region on chromosome 5 (5q31.3; Fig. 6B and 6E). We also observed a weaker 357 
enrichment for the opposite dynamic (impaired B to A transitions; Fig. 6D), but we note that this analysis 358 
was limited to autosomes since compartment transitions of the X chromosome could not be assessed in 359 
female hESC-CMs due to the confounding factor of X inactivation (Fields et al., 2017). In sum, lamin A/C 360 
haploinsufficiency in developing hiPSC-CMs results in highly selective dysregulation of chromatin 361 
compartmentalization, particularly for a handful of genomic hotspots that fail to transition from the active 362 
to inactive compartment. We will refer to these as lamin A/C-sensitive B domains. 363 
 364 
Dysregulation of lamin A/C-sensitive B domains leads to ectopic expression of non-cardiac genes 365 
We then assessed the functional consequences of compartment dysregulation due to lamin A/C 366 
haploinsufficiency. Strikingly, we observed almost no overlap between genes within lamin A/C-sensitive 367 
domains and genes significantly and strongly up- or downregulated in mutant cells (Fig. S4B). 368 
Accordingly, there were no significant changes in the average expression of genes found in lamin A/C-369 
sensitive domains in mutant versus corrected controls (Fig. 7A). Nevertheless, we noticed a small number 370 
of genes located in lamin A/C-sensitive B domains that were expressed at very low levels in corrected 371 
hiPSC-CMs and upregulated in mutant cells (29 genes with an average fold-change > 2; Fig. 7A and Fig. 372 
S4C). These genes were significantly enriched for three chromosome locations (Fig. 7B), two of which 373 
corresponded to the lamin A/C-sensitive hotspots 5q31.3 and 19q13.33 (Fig. 6E), and were associated 374 
with neuronal development (Fig. 7B, and Table S5). 375 
 376 
Of note, most genes in the group just described had not been determined as differentially expressed 377 
based on RNA-seq analysis using Cufflinks since lowly-expressed genes are subject to strong negative 378 
penalization when calculating the q score due to the challenges in robustly assessing their expression 379 
(Trapnell et al., 2012, 2010). This explains their absence in the lists used for the overlap shown in 380 
Supplemental Figure 4B. To increase our confidence with these results we validated the expression of 381 
several genes within this class by RT-qPCR. Moreover, to exclude that such gene expression differences 382 
were simply explained by a differentiation delay in mutant hiPSC-CMs, we analyzed hiPSC-CMs matured 383 
either by longer 2D culture or by the generation of 3D-EHTs. Remarkably, nearly all genes tested showed 384 
consistent significant upregulation in mutant samples (Fig. 7C-D and Fig. S4D-E). These findings 385 
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (which wasthis version posted February 19, 2019. ; https://doi.org/10.1101/555250doi: bioRxiv preprint 
 13 
confirmed that impaired transition to the B compartment of selected lamin A/C-sensitive domains leads 386 
to upregulation of multiple non-cardiac genes that would otherwise be silenced during cardiomyocyte 387 
differentiation. 388 
 389 
Ectopic P/Q-type and potentiated L-type calcium currents contribute to electrophysiological 390 
abnormalities of lamin A/C haploinsufficient hiPSC-CMs 391 
Genes found in lamin A/C-sensitive B domains and upregulated in mutant hiPSC-CMs included multiple 392 
factors with either unknown function, such as the putative uncharacterized protein C19orf81, or with 393 
established roles in the nervous system but not normally expressed in the heart (Fig. 7C-D and Fig. S4D-394 
E). This group included genes from all of the three protocadherin clusters on chromosome 5 (alpha, beta, 395 
and gamma, exemplified by PCDHA10, PCDHB15, and PCHDGB4; Chen and Maniatis, 2013), LRRC4B 396 
(encoding for the postsynaptic cell adhesion molecule NGL-3; Maruo et al., 2017), SYT3 (involved in 397 
postsynaptic endocytosis; Awasthi et al., 2018), and CACNA1A (which encodes for the pore-forming 398 
subunit of neuronal P/Q-type calcium channels; Rajakulendran et al., 2012).  399 
 400 
CACNA1A appeared particularly interesting given the prolonged action potential duration observed in 401 
mutant hiPSC-CM populations. Indeed, the depolarizing ICa,P and ICa,Q currents resulting from the protein 402 
product of CACNA1A are known to be strong and long-lasting, even more so than ICa,L currents typical of 403 
hiPSC-CMs (Catterall et al., 2005; Nimmrich and Gross, 2012). Thus, we tested whether ICa,P and ICa,Q 404 
currents contributed to the electrophysiological abnormalities of mutant cells by inhibiting such currents 405 
using two structurally unrelated highly-specific inhibitors derived from spider venoms: ω-Conotoxin MVIIC 406 
and ω-Agatoxin TK (Adams et al., 1993; McDonough et al., 1996; Nimmrich and Gross, 2012). MEA 407 
experiments demonstrated that both toxins led to a modest but significant decrease in the FPDc in 408 
monolayers of mutant hiPSC-CMs, while they did not affect their depolarization amplitude (Fig. 8A-B). 409 
On the other hand, neither toxin had a significant effect on the FPDc in corrected controls (Fig. 8A-B), 410 
confirming that ICa,P and ICa,Q currents do not play a role in cardiac depolarization in physiological 411 
conditions, and establishing that the toxins had no overt non-specific effects on hiPSC-CM 412 
electrophysiology at the doses tested. These experiments indicated that ectopic expression of CACNA1A 413 
in mutant cells and the resulting P/Q-type calcium currents contribute to the prolonged depolarization 414 
observed in lamin A/C haploinsufficient hiPSC-CMs. 415 
 416 
As mentioned above, we also observed CACNA1C upregulation and KCNQ1 downregulation in mutant 417 
hiPSC-CMs at day 14 of differentiation (Fig. 4A). RT-qPCR analyses in hiPSC-CMs matured for a longer 418 
period in 2D monolayers or in 3D-EHTs indicated that KCNQ1 downregulation was specific to early 419 
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hiPSC-CMs (Fig. 8C-D). On the other hand, upregulation of CACNA1C was maintained in more mature 420 
hiPSC-CMs (Fig. 8C-D). Of note, CACNA1C is a gene always found in the A chromatin compartment 421 
throughout hiPSC-CM differentiation (Fields et al., 2017), and such localization was unaltered in mutant 422 
hiPSC-CMs (Table S4). Given the established role of ICa,L in the development and maintenance of the 423 
cardiac action potential (Catterall et al., 2005), we tested if its inhibition with the L-type calcium blocker 424 
verapamil could revert the electrophysiological abnormalities of mutant hiPSC-CMs. Remarkably, low 425 
concentrations of verapamil markedly reduced both the FPDc and the spike amplitude of mutant hiPSC-426 
CM monolayers, while they had little or no effect on corrected controls (Fig. 8E). Overall, we conclude 427 
that the combination of ectopic P/Q-type calcium currents due to aberrant chromatin compartment 428 
dynamics, and of enhanced L-type calcium currents via other epigenetic mechanisms lead to the 429 




Disease modeling of cardiac laminopathy in developing cardiomyocytes 434 
Previous efforts to study cardiac laminopathy using patient-derived hiPSCs have relied on hiPSCs from 435 
unrelated healthy subjects as controls (Siu et al., 2012; Lee et al., 2017), a strategy which has known 436 
limitations (Sala et al., 2017). By developing a method to generate isogenic control hiPSCs through 437 
entirely scarless gene correction we provide a more rigorous in vitro model of cardiac laminopathy due 438 
to lamin A/C haploinsufficiency, which we apply to broaden our understanding of the disease with respect 439 
to cardiac electrophysiology and contractility.  440 
 441 
Because the earliest manifestation of cardiac laminopathy is severe electrical abnormalities in the 442 
myocardium (Van Rijsingen et al., 2012; Hasselberg et al., 2018; Kumar et al., 2016), our observations 443 
of aberrant electrophysiological properties in mutant hiPSC-CMs may be noteworthy. While alterations in 444 
cardiac rhythm could have been anticipated given the clinical manifestations of this disease, we were 445 
surprised to note increased FPDc and action potential duration. The FPD is the in vitro analogue of the 446 
QT interval measured by electrocardiogram (which indicates the interval between ventricular 447 
depolarization and repolarization). Genetic or acquired prolongation of QT interval is a strong risk factor 448 
for development of severe arrhythmias (Vandael et al., 2017), and QT interval prolongation has been 449 
reported in patients with LMNA mutations causing cardiac laminopathy (Pan et al., 2009), Emery-Dreifuss 450 
muscular dystrophy (Russo et al., 2012), and Hutchinson-Gilford progeria syndrome (Merideth et al., 451 
2008). Although prolonged QT has not been widely described as a hallmark of cardiac laminopathy, we 452 
speculate that this could be an underappreciated early clinical phenotype. Prolonged QTc and 453 
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subsequent increase in calcium influx might predispose patients to cardiac arrhythmias and/or could be 454 
an early marker of a broader conduction system disease. 455 
 456 
A striking phenotype of the laminopathic cardiomyocytes was their enhanced contractility in monolayers 457 
and in engineered heart tissues. Increased contractility can be explained by the prolonged action 458 
potentials and stronger calcium fluxes that these myocytes exhibit. At a first glance, greater contractility 459 
might appear to conflict with the clinical phenotype of some laminopathy patients who develop systolic 460 
heart failure. However, in contrast to the early-onset and highly penetrant malignant conduction disease, 461 
left ventricular dilatation and systolic failure is experienced by just a fraction of cardiac laminopathy 462 
patients and only after years after the initial diagnosis (Van Berlo et al., 2005; Kumar et al., 2016; Tobita 463 
et al., 2018). Moreover, heart failure is a complex disease that involves multiple cell types as well as the 464 
extracellular matrix (Metra and Teerlink, 2017). Thus, we propose that the systolic hyperfunction and 465 
diastolic dysfunction of lamin A/C haploinsufficient hiPSC-CMs might reflect an early and cell-466 
autonomous phenotype of cardiac laminopathy, which over the years can evolve into an organ-level 467 
disease characterized by decreased systolic function. A possible mechanism for this could be the chronic 468 
calcium overload in laminopathic cardiomyocytes, as this is a well-established stimulus that can lead to 469 
dilated cardiomyopathy due to activation of signaling pathways such as calcineurin/NFAT (Molkentin et 470 
al., 1998; Nakamura et al., 2008; Zhang et al., 2016). Additionally, it was previously shown that 471 
laminopathic cardiomyocytes are highly sensitive to apoptosis (Ho et al., 2011; Lee et al., 2017), which 472 
could over the years contribute to the development of severe cardiac fibrosis that is typical in cardiac 473 
laminopathy patients (van Tintelen et al., 2007b; Fontana et al., 2013; Tobita et al., 2018). A corollary of 474 
these intriguing hypotheses is that medical interventions during the early phases of the disease, such as 475 
the use of calcium antagonists and/or anti-apoptotic agents (Lee et al., 2014; Nie et al., 2018), may be 476 
able to prevent the development of heart failure in cardiac laminopathy patients. 477 
 478 
Chromatin architecture changes in lamin A/C haploinsufficient cardiomyocytes 479 
Our study’s primary goal was to study the pathogenesis of cardiac laminopathy. Nevertheless, by 480 
integrating Hi-C results from lamin A/C haploinsufficient and control hiPSC-CMs with our previous Hi-C 481 
dataset at different stages of human cardiogenesis (Fields et al., 2017), we were also able to shed light 482 
on the physiological roles of lamin A/C during cardiac specification. We observed that lamin A/C 483 
haploinsufficiency reduces inter-chromosomal interactions, reinforces the separation between small and 484 
large chromosomes, increases the long-range segregation of A and B chromatin compartments, and 485 
strengthens short-range homotypic interactions within the A compartment. Intriguingly, most of these 486 
effects antagonize the chromatin organization dynamics that normally occur during human cardiogenesis 487 
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(Fields et al., 2017). These data demonstrate that lamin A/C is an important mediator of physiological 488 
changes in nuclear architecture during differentiation, in agreement with its gradual upregulation as cells 489 
exit the pluripotent state and commit to the cardiac lineage. 490 
 491 
The major hypothesis going into this study was that lamin A/C haploinsufficiency would induce 492 
widespread gene dysregulation due to inappropriate A/B compartmentalization, the so-called “chromatin 493 
hypothesis” for the pathogenesis of cardiac laminopathy (Worman and Courvalin, 2004; Cattin et al., 494 
2013). This hypothesis was not robustly supported. RNA-seq analysis showed that only ~325 genes were 495 
up- or down-regulated in laminopathic cardiomyocytes. Analysis of A/B compartment changes revealed 496 
that only ~1.2% of the genome changed compartments in LMNA mutants, and these aberrations were 497 
concentrated in hotspots on chromosomes 5 and 19. Surprisingly, the overlap between strong 498 
dysregulation in gene expression and compartment aberrations was minimal (less than 2%; Fig. S4B). 499 
As discussed below, the CACNA1A gene is ectopically expressed and resides in an A compartment that 500 
fails to silence during differentiation. Thus, while examples can be found that may contribute to disease, 501 
most of the transcriptional dysregulation appears to result from factors other than errors in 502 
compartmentalization. Overall, these findings do not support the “chromatin hypothesis” for the 503 
pathogenesis of cardiac laminopathy. On the other hand, our results agree with previous findings from 504 
mouse embryonic stem cells (mESCs), in which depletion of B-type nuclear lamins results in minimal 505 
changes in A/B compartmentalization (Amendola and van Steensel, 2015; Zheng et al., 2015, 2018). Our 506 
results establish that while A-type lamins seem to participate in chromatin organization in developing 507 
cardiomyocytes, lamin A/C haploinsufficiency leads to only modest alterations in A/B 508 
compartmentalization even in mechanically active cells. 509 
 510 
Interestingly, we identify CACNA1A as a disease-associated gene linked to alterations of A/B 511 
compartmentalization. CACNA1A is normally expressed throughout the nervous system with the highest 512 
expression on Purkinje neurons in the cerebellum and in cerebellar granular cells (Nimmrich and Gross, 513 
2012). Its ectopic expression and the modest contribution of the resulting P/Q-type calcium currents on 514 
FPDc prolongation in lamin A/C haploinsufficient hiPSC-CMs suggests that this may represent a 515 
therapeutic target to ameliorate the electrical abnormalities in the myocardium of cardiac laminopathy 516 
patients. Further assessments of CACNA1A expression in patient-derived primary samples will be of high 517 
interest. We also identified the locus containing the three protocadherin clusters as another lamin A/C-518 
sensitive B domain associated to ectopic gene expression. Protocadherin genes are well-established 519 
mediators of accurate neuronal connectivity, and are not normally expressed in the heart (Hayashi and 520 
Takeichi, 2015). It is an intriguing possibility that ectopic protocadherin expression may change cellular 521 
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adhesion patterns in the cardiac conduction system, which may contribute to conduction disease in 522 
cardiac laminopathy. Other interesting targets of chromatin compartment dysregulation in lamin A/C 523 
haploinsufficient hiPSC-CMs are GPC4, whose upregulation might explain the incomplete silencing of 524 
cardiac progenitor genes (Strate et al., 2015), and CLEC11A (also known as stem cell growth factor), a 525 
cytokine normally involved in bone marrow homeostasis but upregulated in cardiac disease (Wang et al., 526 
2013). 527 
 528 
If chromatin compartment alterations do not directly explain the majority of gene expression changes 529 
observed in lamin A/C haploinsufficient hiPSC-CMs, what is driving these changes? An important 530 
example of ths behaviour is CACNA1C, which is upregulated in mutant cells while not changing 531 
compartmentalization. At least two non-exclusive possibilities come to mind. First, it remains possible 532 
that alterations in chromatin organization play a primary role, albeit not in the form of outright changes in 533 
A/B compartmentalization. For instance, it was reported that B-type lamins can indirectly affect the 534 
expression of genes within the nuclear interior by affecting the interaction between TADs as a 535 
consequence of distal alterations in LAD compaction (Zheng et al., 2018). It is thus possible that A-type 536 
lamins might have a similar role, which will be interesting to test in detail in future studies. A second 537 
possibility for compartment-independent gene expression changes might be the result of changes in 538 
intracellular signaling pathways such as MAPK and mTOR. Indeed, such pathways have well-established 539 
links with the nuclear lamina (Dobrzynska et al., 2016), and are upregulated in animal models of cardiac 540 
laminopathy (Muchir et al., 2007, 2012; Choi et al., 2012). 541 
 542 
Emerging evidence suggests that nonsense/haploinsufficency mutations in LMNA may have a different 543 
pathogenesis than missense mutations. We have recently collaborated to study a previously described 544 
heterozygous K219T missense mutation in LMNA (Roncarati et al., 2013). Interestingly, this mutation 545 
leads to distinct electrophysiological abnormalities, namely reduced peak sodium current and diminished 546 
conduction velocity, which are caused by downregulation of SCN5A as result of closer proximity to the 547 
nuclear lamina and increased H3K27me3 (Salvarani, Crasto et al., manuscript in preparation). In the 548 
current study we have not observed a similar reduction of SCN5A expression in lamin A/C 549 
haploinsufficient hiPSC-CMs (Fig. S2D). Furthermore, our Hi-C data indicate that the SCN5A gene is 550 
found in a chromatin domain which is always part of the A compartment both throughout normal cardiac 551 
differentiation (Fields et al., 2017) and in lamin A/C haploinsufficient hiPSC-CMs (Table S4). These 552 
observations prompt the intriguing hypothesis that haploinsufficient and missense mutations in LMNA 553 
might lead to cardiac laminopathy via distinct molecular mechanisms.  554 
 555 
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In conclusion, our work establishes that while lamin A/C haploinsufficient hiPSC-CMs show marked 556 
alterations in electrophysiology, contractility, and chromosomal topology, phenotypic changes cannot, for 557 
the most part, be directly explained by alterations in chromatin compartmentalization. With this in mind, 558 
it is important to mention that this study does not come without limitations. We acknowledge that modeling 559 
diseases of the adult heart in immature hiPSC-CMs suffers from inherent drawbacks. It is possible that 560 
functional chromatin dysregulation could be more important in adult myocytes subjected to high levels of 561 
mechanical stress in vivo. Addressing this aspect will require substantial advances in our ability to mature 562 
hiPSC-CMs and/or improvements of genome-wide chromatin conformation capture technologies in order 563 
to reliably measure chromatin architecture from small numbers of myocytes isolated from precious 564 
primary samples. Furthermore, future studies will be required to test whether other types of mutations 565 
(such as missense changes like the aforementioned K219T mutation) result in more substantial genome-566 
wide alterations in chromatin topology than what was observed following lamin A/C haploinsufficiency. 567 
All considered, our work provides a stepping stone towards understanding the relevance of the 568 
“chromatin hypothesis” in the pathogenesis of cardiac laminopathy, while it also sheds light on the 569 
physiological roles of A-type lamins in the chromatin dynamics that accompany human cardiogenesis. 570 
 571 
Materials and methods 572 
 573 
hiPSC culture and differentiation 574 
Human induced pluripotent stem cells (hiPSCs) were cultured and differentiated into cardiomyocytes 575 
(hiPSC-CMs) with minor modifications of previously described methods (Burridge et al., 2014; Fields et 576 
al., 2017). hiPSCs were cultured on plates pre-coated with 0.5 µg/cm2 recombinant human Laminin-521 577 
matrix (rhLaminin521; Biolamina) with daily changes of antibiotic-free Essential 8 (E8) media 578 
(ThermoFisher). Cells were passaged as small clumps with Versene (ThermoFisher), and 10 µM Y-27632 579 
(Tocris) was added for the first 16 hr. 580 
 581 
For hiPSC-CM generation, cells were passaged as single cells with Versene, and seeded at a density of 582 
2.5 x 105 per well of a 12-well plate pre-coated with 2 µg/cm2 rhLaminin521 (denoted day -2). After 24 hr 583 
media was changed to E8 with 1 µM CHIR-99021 (Cayman), denoted day -1. On day 0 media was 584 
changed to RBA media (RPMI 1640 with glutamine [ThermoFisher] supplemented with 500 µg/ml BSA 585 
and 213 µg/ml ascorbic acid [both from Sigma-Aldrich]) supplemented with 4 µM CHIR-99021. At day 2, 586 
media was changed to RBA with 2 µM WNT-C59 (Selleckchem). On day 4, media was changed to RBA. 587 
On day 6, media was changed to RPMI-B27 media (RPMI with 1x B-27 supplement, both from Thermo 588 
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Fisher), with further media changes every other day. Beating was first observed between day 7 and day 589 
9, and cells were cultured until day 14 before collection (unless otherwise indicated). hiPSC-CMs to be 590 
used for functional assays of cardiac electrophysiology or contractility were preconditioned with a 30 min 591 
heat-shock at 42º on day 13, and cryopreserved at day 14 following single-cell dissociation using 0.25% 592 
w/vol Trypsin (ThermoFisher) in Versene. 593 
 594 
Frozen hiPSC-CM stocks were thawed and seeded at a density of 2 x 105 cells/cm2 onto rhLamin521 pre-595 
coated dishes (2 µg/ml) in RPMI-B27, which was supplemented with 10 µM Y-27632 and 5% FBS 596 
(ThermoFisher) for the first 16 hr. hiPSC-CMs were then cultured in RPMI-B27 with media changes every 597 
other day. After one week (day 21 of differentiation), hiPSC-CMs were dissociated to single cell using 598 
0.05% Trypsin-EDTA (ThermoFisher), and seeded at the desired density the downstream assays. 599 
 600 
Gene editing 601 
hiPSCs with a heterozygous c.672C>T mutation in the LMNA gene (resulting in p.Arg225*, or R225X) 602 
were generated through lentiviral reprogramming of dermal fibroblasts from a 56 year-old male patient 603 
with severe cardiac laminopathy (Siu et al., 2012). Cells were obtained at passage 29, adapted to culture 604 
in E8/rhLaminin521, and banked at passage 34. These hiPSC stocks were confirmed to be Mycoplasma 605 
negative (MycoAlert Detection Kit, Lonza), and proved euploid by conventional G-banding karyotyping 606 
(Diagnostic Cytogenetics Inc, Seattle). Cell identity was tested by Sanger sequencing of a genomic PCR 607 
product for exon 4 of LMNA (PCR primers: 5’- GGCTGGGTGATGACAGACTT-3’ and 5’-608 
TACTGCTCCACCTGGTCCTC-3’; sequencing primer 5’- GCCCTAGTGGACAGGGAGTT-3’), which 609 
confirmed the expected c.672C>T heterozygous mutation. 610 
 611 
The mutation was corrected into the wild-type allele by adapting a previously described two-step method 612 
for scarless genome editing relying on CRISPR/Cas9-facilitated homologous recombination of a targeting 613 
vector containing the wild-type allele in one homology arm, and an excisable piggyBac drug resistance 614 
cassette (Fig. S1A; Yusa, 2013; Yusa et al., 2011). Since the c.672C>T mutation lies close to the 3’ splice 615 
acceptor site of exon 4 (Fig. S1B), we reasoned that any intergenic mutation could have poorly 616 
predictable effects on LMNA splicing. To avoid any kind of genomic scar, we identified a suitable 617 
endogenous “TTAA” site in the third intron of LMNA and located 151 bp upstream to the c.672C>T 618 
mutation in exon 4 (Fig. S1B). Further, we designed single guide RNAs (sgRNAs) spanning such TTAA 619 
site, so that only the endogenous allele could be cut by CRISPR/Cas9. This strategy allowed us to avoid 620 
inserting any additional mutation onto one of homology arms in the targeting vector (such as those 621 
classically used to disrupt the PAM site). Two sgRNAs were designed using mit.crispr.edu, and had a 622 
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score higher than 75%, indicating a very high in-silico predicted specificity (sgRNA 1: 5’- 623 
CTACCAGCCCCACTTTAACC-’3 and sgRNA2 5’-TCAGCTCCCAGGTTAAAGTG-3’, sequences without 624 
PAM site). To further decrease the risk of CRISPR/Cas9 off-target activity, we adopted the enhanced 625 
specificity Streptococcus Pyogenes Cas9 (eSpCas9) developed by Dr. Feng Zhang and colleagues 626 
(Slaymaker et al., 2015). The sgRNA was cloned into the eSpCas9(1.1) plasmid (Addgene #71784) using 627 
a standard method based on restriction digestion with BbsI followed by ligation of a double-stranded oligo 628 
(Ran et al., 2013). The resulting plasmids were named eSpCas9(1.1)_LMNA_sgRNA1 and 629 
eSpCas9(1.1)_LMNA_sgRNA2. The sequences were confirmed by Sanger sequencing, and the sgRNAs 630 
were validated to have a high on-target activity as measured by T7E1 assay in HEK293 cells (which was 631 
comparable to that observed using wild-type SpCas9). 632 
 633 
The LMNA targeting vector was constructed starting from the MV-PGK-Puro-TK_SGK-005 plasmid 634 
(Transposagen), which contains a piggyBac transposon encoding for a PGK-EM7 promoter-driven dual 635 
positive/negative selection cassette (puromycin N-acetlytransferase, ensuring resistance to puromycin, 636 
and truncated Herpes simplex virus thymidine kinase, conferring sensitivity to ganciclovir or its analog 637 
fialuridine). First, the piggyBac cassette was excised using NsiI and BsiWI and isolated. Then, a 638 
backbone with ends suitable for the subsequent overlap-based assembly was obtained from this same 639 
plasmid after removal of the piggyBac cassette using NotI and AscI. Finally, these two fragments were 640 
re-assembled together with two PCR products representing the 5’ and 3’ homology arms to the LMNA 641 
gene. The two homology arms were approximately 1 Kb long, and were amplified from genomic DNA of 642 
RUES2 human embryonic stem cells (hESCs) using primers: 5’- GGTCCCGGCATCCGATACCCAATG-643 
GCGCGCCCGTACTTCAGGCTTCAGCAGT-3’ and 5’- AAAGAGAGAGCAATATTTCAAGAATGCATG-644 
CGTCAATTTTACGCAGACTATCTTTCTAGGGTTAACCTGGGAGCTGAGTGC-3’ (for the 5’ homology 645 
arm); 5’- AATTTTACGCATGATTATCTTTAACGTACGTCACAATATGATTATCTTTCTAGGGTTAAAGT-646 
GGGGCTGGTAGTG-3’ and 5’-CGAATGCGTCGAGATATTGGGTCGCGGCCGCCCTGTCACAAATAG-647 
CACAGCC-3’ (for the 3’ homology arm), and Q5 High-Fidelity DNA Polymerase (New England Biolabs) 648 
according to the manufacturer’s instructions. The four-way assembly reaction was performed using 649 
NEBuilder HiFi DNA Assembly Kit (New England Biolabs) according to the manufacturer’s instructions, 650 
and the resulting targeting plasmid was named pbLMNA_R225R. Sanger sequencing confirmed that the 651 
3’ homology arm contained the wild-type R225R allele, while the remaining genomic sequence of both 652 
homology arms was identical to that of the R225X hiPSC line as no SNPs were identified. The cloning 653 
strategy was designed so that during PCR the “TTAA” site was inserted both at the end of the 5’ homology 654 
arm and at the start of the 3’ homology arm, ensuring that the piggyBac cassette contained within could 655 
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be excised using transposase while leaving behind a single “TTAA” matching the original genomic 656 
sequence (Fig. S1A). 657 
 658 
For the first gene targeting step, 7.5 x 104 hiPSCs were seeded in each well of 6-well plate and 659 
immediately transfected using GeneJuice (Millipore) according to the manufacturer’s instructions. Briefly, 660 
for each well 3 µl of GeneJuice was mixed with 100 µl of Opti-MEM (ThermoFisher Scientific) and 661 
incubated for 5 min at room temperature. 1 µg of DNA was added to the transfection solution (equally 662 
divided between pbLMNA_R225R and either eSpCas9(1.1)_LMNA_sgRNA1 or 663 
eSpCas9(1.1)_LMNA_sgRNA2), which was further incubated for 15 min at room temperature and finally 664 
added to the cell suspension. After 16 hr from transfection, cells were washed with DPBS and cultured 665 
for another 3 days. Gene targeted cells were selected by adding 1 µg/ml puromycin to the media for 4 666 
days, after which the dose was reduced to 0.5 µg/ml. 10 µM Y-27362 was added for the first 48 hr of 667 
selection. Puromycin was then maintained at all times until the second gene targeting step to prevent 668 
silencing of the piggyBac transgene. After 7 days from the transfection, 10-15 individual and well-669 
separated colonies could be identified in each well of 6-well plate, indicating that they likely arose from 670 
clonal expansion of a single gene-edited hiPSC. Colonies were manually picked following gentle 671 
treatment with Versene to facilitate their detachment from the matrix, and individually expanded as 672 
individual lines. Clones were screened by genomic PCR using LongAmp Taq Polymerase (New England 673 
Biolabs) according to manufacturer’s instructions, except that all reactions were performed using an 674 
annealing temperature of 63 °C and an extension time of 2 min. The primer sequences are reported in 675 
Supplemental Table 6, and the genotyping strategies are illustrated in Supplemental Figure 1. Briefly, 676 
junctional PCRs for both the 5’ and 3’ integration site (5’- and 3’-INT) were used to confirm site-specific 677 
integration, while locus PCRs were used to monitor the presence of residual wild-type alleles. This 678 
allowed to discriminate homozygous clones from heterozygous ones or mixed cell populations. Finally, 679 
PCRs of the targeting vector backbone (5’- and 3’-BB) were performed to exclude random integration of 680 
the plasmid elsewhere in the genome. Homozygous clones with only on-target integration events were 681 
selected (3 out of 18 and 2 out of 24 for sgRNA 1 and sgRNA 2, respectively). These positive clones 682 
were further characterized by Sanger sequencing of the 5’- and 3’-INT PCR products to confirm the 683 
presence of the wild-type R225R allele in homozygosity (found in all of the 5 lines) and exclude other 684 
unwanted mutations elsewhere in the locus (absent in all 5 lines). Two clones (one for each sgRNA) were 685 
karyotyped by standard G-banding, which confirmed their euploidy, and were therefore selected for the 686 
second gene targeting step. These clones were named pb R225R g1 and pb R225R g2 (Fig. S1C). 687 
 688 
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To remove the piggyBac and restore the LMNA locus to its original form, pb R225R g1 and pb R225R g2 689 
hiPSCs were transfected as described above but using 1 µg of excision-only piggyBac transposase 690 
expression vector (PBx; Transposagen). Puromycin was removed from the media the day before 691 
transfection, and subsequently omitted. After 3 days from the transfection, the populations were 692 
passaged as single cells, and 1 x 104 cells were seeded per 10 cm plate in the presence of 10 µM Y-693 
27362. On the next day, negative selection of cells still possessing the piggyBac cassette was initiated 694 
by adding 200 nM fialuridine. 10 µM Y-27362 was added for the subsequent 48 hr. Selection was 695 
complete after 5 days, at which point 10-50 individual and well-separated colonies could be identified in 696 
each 10 cm dish. Individual colonies were isolated, clonally expanded, and screened by genomic PCR 697 
as described above to identify those with homozygous reconstitution of the wild-type allele (5 out of 30 698 
and 6 out of 39 for sgRNA 1 and sgRNA2, respectively). These were further characterized by sequencing 699 
to ensure that the sequence surrounding the “TTAA” site was faithfully reconstituted upon piggyBac 700 
excision (confirmed in a subset of 4 lines, 2 for each sgRNA; Fig. S1C-D). Two clones (one for each 701 
sgRNA), were karyotyped by standard G-banding, which confirmed their euploidy, and therefore selected 702 
for subsequent functional experiments. These clones were named R225R g1-15 and R225R g1-38, and 703 
are referred to in the text and figures as Corrected 1 and Corrected 2 (or Corr.1 and Corr.2).  704 
 705 
Parental R225X hiPSCs (referred to in the text and figures as Mutant or Mut) were cultured in parallel 706 
throughout the whole gene editing procedure to provide a passage-matched control, and were re-banked 707 
at passage 49 together with Corrected 1 and Corrected 2. These cells were confirmed to be euploid by 708 
G-banding karyotyping. Mutant and Corrected hiPSCs to be used for derivation of hiPSC-CMs were 709 
cultured between passage 50 to 60 before resorting to a new frozen stock. 710 
 711 
MEA 712 
Multi-electrode array (MEA) analyses were performed on hiPSC-CM monolayers at day 30 of 713 
differentiation. hiPSC-CMs at day 21 of differentiation were seeded at a density of 5 x 104 cells per well 714 
of 48-well MEA plates (CytoView MEA 48; Axion Byosystems) pre-coated with rhLaminin521 (2 µg/ml). 715 
Cells were cultured in RPMI-B27 with media changes every other day. After 9 days (day 30 of 716 
differentiation), cells were prepared for MEA analysis by changing the culture media to Tyrode’s buffer 717 
(140 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 0.33 mM NaH2PO4, 5 mM D-glucose, and 10 718 
mM HEPES; pH adjusted to 7.36) pre-warmed at 37 ºC. After 10 min of equilibration in Tyrode’s buffer 719 
at 37 ºC, MEA data were acquired for 5 min using the Maestro MEA system (Axion Biosystems) using 720 
standard recording settings for spontaneous cardiac field potentials. Data acquisition and automated data 721 
analysis was performed using Axis software, version 2.1. Standard acquisition settings have 130 × gain, 722 
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and record from 1 to 25 000 Hz, with a low-pass digital filter of 2 kHz for noise reduction. Automated data 723 
analysis was focused on the 30 most stable beats within the recording period. The beat detection 724 
threshold was 100 µV, and the field potential duration (FPD) detection utilized an inflection search 725 
algorithm with the threshold set at 1.5 × noise to detect the T wave. The FPD was corrected for the beat 726 
period (FPDc) according to the Fridericia’s formula: FPDc = FPD / (beat period)1/3 (Rast et al., 2016; 727 
Asakura et al., 2015). Reported results for individual wells were calculated by averaging all of the 728 
electrodes. In certain instances, poor signal quality and/or irregularity of field potential behavior prevented 729 
the calculation of certain parameters (such as FPD). The presented data constitutes all recorded values 730 
that could be reliably measured by the software based on automatic quality-control thresholds. 731 
 732 
For pharmacological studies of P/Q- and L-type calcium current inhibition, Tyrode’s buffer was 733 
supplemented with 2 µM ω-Conotoxin MVIIC, 0.5 µM ω-Agatoxin TK, or 0.001-0.5 µM verapamil (all from 734 
Tocris). hiPSC-CMs were incubated at 37 ºC for 20 min or 10 min (for ω-Conotoxin and ω-Agatoxin, or 735 
verapamil, respectively) before MEA data acquisition. 736 
 737 
Whole cell patch clamp 738 
Whole-cell patch clamp recordings were obtained from individual hiPSC-CMs at day 30 of differentiation. 739 
hiPSC-CMs at day 21 of differentiation were seeded at a density of 4.5 x 105 cells per well of 35-mm 740 
glass-bottom FluoroDish with nanopatterned surfaces pre-coated with rhLaminin521 (2 µg/ml). 741 
Anisotropically nanofabricated substrata (ANFS) with 800 nm topographic features were fabricated via 742 
UV-assisted capillary force lithography as previously described (Macadangdang et al., 2015). First, liquid 743 
polyurethane acrylate (PUA) prepolymer was drop dispensed onto a silicon master mold. A transparent 744 
polyester film (PET) was then placed on top of the dispensed PUA. After exposure to UV radiation (λ = 745 
250–400 nm), the film was peeled away from the silicon master, creating a PUA mold. A polyurethane-746 
based prepolymer (NOA76, Norland Products Inc.) was then drop dispensed onto standard glass 747 
coverslips and the PUA mold was placed on top. The mold was then exposed to UV radiation for curing. 748 
After curing, the PUA mold was peeled off, leaving behind an ANFS for cell culture. Dishes were sterilized 749 
and activated by gas plasma treatment before coating with rhLaminin521. After 9 days, cells were 750 
assayed by whole-cell patch clamp on the 37 °C heated stage of an inverted DIC microscope (Nikon) 751 
connected to an EPC10 patch clamp amplifier and computer running Patchmaster software version 752 
2x73.2 (HEKA). Cells on patterned coverslips were loaded onto the stage and bathed in Tyrode’s buffer. 753 
An intracellular recording solution (120 mM L-aspartic acid, 20 mM KCl, 5 mM NaCl, 1 mM MgCl2, 3 mM 754 
Mg2+-ATP, 5 mM EGTA, and 10 mM HEPES) was used in conjunction with borosilicate glass patch 755 
pipettes (World Precision Instruments) with a resistance in the range of 2–6 MΩ. Offset potentials were 756 
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nulled before formation of a gigaΩ seal and fast and slow capacitance was compensated for in all 757 
recordings. Membrane potentials were corrected by subtraction of a 15 mV liquid junction potential 758 
calculated by the HEKA software. Current injection was controlled by the software and used to hold 759 
patched cells at an artificial resting membrane potential of -70 mV. Cells that required more than 100 pA 760 
of current to achieve a -70 mV resting membrane potential were excluded from analysis as excessive 761 
application of current was taken as indication of poor patch quality and/or membrane integrity. To 762 
generate a single action potential, a 5 ms depolarizing current pulse of 50 nA was then applied and the 763 
resulting voltage change recorded in current clamp mode. Action potential rise times were calculated as 764 
the time taken to reach 90% maximum action potential amplitude from 10% of the maximum amplitude. 765 
The exponential time constant (τ) was calculated from 90% to 10% repolarization of the action potential. 766 
Action potential duration was calculated as the time delay between 10% of the maximum depolarization 767 
and 90% repolarization from the maximum action potential amplitude. Gap-free recordings of 768 
spontaneous cardiomyocyte activity were then collected for 30 seconds with 0 pA current injection to 769 
provide a measure of the maximum diastolic membrane potential held by the cell without current input.  770 
 771 
Assessment of intracellular calcium fluxes 772 
Calcium fluxes were assessed in hiPSC-CM monolayers at day 30 of differentiation. hiPSC-CMs at day 773 
21 of differentiation were seeded at a density of 5 x 105 cells per well of 6-well plate pre-coated with 774 
rhLaminin521 (2 µg/ml). After 9 days, cells were prepared for imaging by incubation for 30 min at 37 ºC 775 
with 1 µM Fluro-4, AM (ThermoFisher) diluted in culture media. Cells were rinsed in fresh media for 30 776 
min at 37 ºC, and equilibrated in Tyrode’s buffer pre-warmed at 37 ºC for 10 min. hiPSC-CMs were paced 777 
at 1 Hz using a C-Dish for 6-well plate connected to a C-Pace EM cell stimulator (both from IonOptix) 778 
providing biphasic field stimulation (pulses of 10 V/cm for 20 ms). Videos of Fluo-4 fluorescence 779 
(excitation/emission of 494 and 516) were recorded at 20 frames per second (FPS) for at least 5 780 
contractions using a Nikon Ti-E epi-fluorescent microscope with a 20x-objective and 1x coupler between 781 
the microscope and Hamamatsu flash V3 camera. Videos were obtained for at least 20 random fields of 782 
view. A custom Matlab program was used to define the region of interest (ROI, containing an individual 783 
hiPSC-CM), threshold the Fluo-4 intensity based on the surrounding non-fluorescent background, and 784 
track the average ROIFluo-4 fluorescence (F) over time. The relaxation time constant, τ, was determined 785 
by fitting the formula F(t) = Ae-t/τ + B to the decay phase of the Fluo-4 transient profile, where t is time in 786 
seconds and A and B are fitted constants.  787 
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CCQ analysis of cardiac contractility in hiPSC-CM monolayers 788 
Contraction correlation quantification (CCQ) analysis was performed on hiPSC-CM monolayers at day 789 
30 of differentiation. hiPSC-CMs at day 21 of differentiation were seeded at a density of 1 x 106 cells per 790 
well of 6-well plate pre-coated with rhLaminin521 (2 µg/ml). After 9 days, cells were paced at 1 Hz as just 791 
described for the measurement of calcium fluxes. Bright-field videos of at least ten contractions in multiple 792 
random field of views were recorded at 30 fps using a Nikon TS100 microscope with a 20x-objective and 793 
1x coupler between the microscope and a Canon VIXIA HF S20 camera. Videos were analyzed by CCQ 794 
using a custom Matlab script, as previously described (Macadangdang et al., 2015). Briefly, this method 795 
utilizes particle image velocimetry and digital image correlation algorithms to provide relevant contractile 796 
endpoints from bright field video recordings. A reference video frame is divided into a grid of windows of 797 
a set size. Each window is run through a correlation scheme with a second frame, providing the new 798 
location for that window in the second frame. This displacement is converted into a vector map, which 799 
provides contraction angles and, when spatially averaged, contraction magnitudes. The correlation 800 
equation used provides a Gaussian correlation peak with a probabilistic nature that provides sub-pixel 801 
accuracy. 802 
 803 
Generation and biomechanical characterization of 3D-EHTs 804 
3D engineered heart tissues (3D-EHTs) were generated and characterized with minor changes to a 805 
previously described method (Leonard et al., 2018). Racks of polydimethylsiloxane (PDMS) posts were 806 
fabricated by pouring uncured PDMS (Sylgard 184 mixed at a 1:10 curing agent to base ratio) into a 807 
custom acrylic mold. Glass capillary tubes (1.1 mm diameter; Drummond) were cut to length and inserted 808 
into the holes on one side of the mold before curing to render one post in each pair rigid. Post racks were 809 
baked overnight at 65 °C before being peeled from the molds. Racks consisted of six pairs of posts that 810 
were evenly spaced to fit along one row of a standard 24-well plate. Fabricated posts were 12.5 mm long 811 
and 1.5 mm in diameter with a cap structure (2.0 mm diameter for the topmost 0.5 mm) to aide in the 812 
attachment of 3D-EHTs. The center-to-center post spacing (corresponding to pre-compacted 3D-EHT 813 
length) was 8 mm. Prior to casting 3D-EHTs, all 3D printed parts and PDMS posts were sterilized in a 814 
UVO Cleaner (Jetlight, No. 342) for 7 min, submerged in 70% ethanol, and rinsed with sterile deionized 815 
water. Rectangular 2% w/vol agarose/PBS casting troughs (12 mm in length, 4 mm in width, and ~4 mm 816 
in depth) were generated in the bottom of 24-well plates by using custom 3D printed spacers (12 mm x 817 
4 mm in cross section and 13 mm long) as negative molds. PDMS posts racks were positioned upside 818 
down with one rigid-flexible post pair centered in each trough (leaving a 0.5 mm gap between the tip of 819 
the post and the bottom of the casting trough). Each tissue consisted of a 97 μL fibrinogen-media solution 820 
(89 μL of RPMI-B-27; 5.5 μL of 2X DMEM with 20% FBS; and 2.5 μL of 200 mg/mL bovine fibrinogen, 821 
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Sigma-Aldrich) containing 5 x 105 hiPSC-CMs and 5 x 104 supporting HS27a human bone marrow stromal 822 
cells (ATCC), which was chilled and mixed with 3 μL of cold thrombin (at 100 U/mL, Sigma-Aldrich) just 823 
before pipetting into the agarose casting troughs. The 3D-EHT mixtures were incubated for 90 min at 37 824 
°C, at which point the fibrin gels were sufficiently polymerized around the posts to be lubricated in media 825 
and transferred from the casting troughs into a 24-well plate with fresh 3D-EHT media (RPMI-B-27 with 826 
penicillin/streptomycin, and 5 mg/mL aminocaproic acid, Sigma-Aldrich). 3D-EHTs were supplied with 827 
2.5 mL/well of fresh 3D-EHT media three times per week. 828 
 829 
In situ force measurements were performed after 4 weeks from 3D-EHT casting. In order to pace 3D-830 
EHTs, post racks were transferred to a custom-built 24-well plate with carbon electrodes connected 831 
through an electrical stimulator (Astro Med Grass Stimulator, Model S88X) to provide biphasic field 832 
stimulation (5 V/cm for 20 ms durations) during imaging (Leonard et al., 2018). 3D-EHTs were 833 
equilibrated in Tyrode’s buffer (containing 1.8 mM Ca2+) pre-heated to 37 °C and paced at 1 Hz, which 834 
was greater than the average spontaneous twitch frequency of the tissues. Videos of at least ten 835 
contractions were recorded inside a 37 °C heated chamber using a monochrome CMOS camera 836 
(Mightex, SMN-B050-U) with a board lens (The Imaging Source, TBL 8.4-2 5MP). The camera-lens 837 
configuration allowed for a capture rate of 65 frames per second (FPS) with 8.3 μm/pixel resolution and 838 
a field of view of 1536 × 400 pixels, which was sufficient to capture images of the whole 3D-EHT from 839 
rigid to flexible post. A custom Matlab program was used to threshold the images and track the centroid 840 
of the flexible post relative to the centroid of the rigid post. The twitch force profile, Ftwitch(t) = kpost*Δpost(t), 841 
was calculated from the bending stiffness, kpost, and deflection of the flexible post, Δpost, at all time points 842 
(t), where kpost = 0.95 μN/μm was determined from beam bending theory using the dimensions of the 843 
posts and taking the Young’s modulus of PDMS to be 2.5 MPa (Sniadecki and Chen, 2007). The twitch 844 
force and twitch kinetics were calculated from the twitch force profiles using a custom Matlab program. 845 
 846 
RT-qPCR 847 
Quantitative reverse-transcription PCR (RT-qPCR) was performed as previously described for 2D cell 848 
monolayers (Fields et al., 2017) or 3D-EHTs (Leonard et al., 2018). 2D monolayers were lysed in RLT 849 
buffer supplemented with 1% 2-Mercaptoethanol before RNA purification using the RNeasy Mini Kit 850 
(QIAGEN) according to the manufacturer’s instructions and including the on-column DNase digestion 851 
step. cDNA was synthetized by reverse transcription of 500 ng of total RNA using M-MLV RT (Invitrogen) 852 
and random hexamer priming according to the manufacturer’s protocol and including RNase OUT 853 
(Invitrogen). RT-qPCR was performed in technical duplicate with SYBR Select Master Mix (Applied 854 
Biosystems) using 10 ng of cDNA and 400 nM forward and reverse primers. Reactions were run for 40 855 
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cycles on a 7900HT Fast Real-Time PCR System (Applied Biosystem, 4329001), all according to the 856 
manufacturer’s instructions, Gene expression relative to the housekeeping gene RPLP0 was calculated 857 
using the ∆Ct method as 2(Ct gene – Ct housekeeping). Where indicated, gene expression was further normalized 858 
to a control condition (which was set at the arbitrary value of 1). Primers were designed using PrimerBlast, 859 
and confirmed to amplify a single product. A complete list can be found in Supplemental Table 7. 860 
 861 
For 3D-EHTs, RNA was extracted using RNeasy Plus Micro Kit (QIAGEN) according to the 862 
manufacturer’s instructions except for the following modifications. Individual 3D-EHTs were pre-digested 863 
using 2 mg/ml Proteinase K in 100 µl DPBS for 10 min at 56 °C in agitation. Cells were then lysed by 864 
adding 350 µl of RLT Plus Buffer supplemented with 1% 2-Mercaptoethanol, and cleared through the 865 
gDNA Eliminator Mini Spin Column. The RNA lysate was finally prepared for binding to the RNeasy 866 
MinElute Spin Column by adding 250 µl of 200 proof ethanol. All subsequent steps were performed 867 
according to the supplier’s recommendations. 10 µl of eluted RNA (corresponding to 50-100 ng) were 868 
subjected to reverse transcription, and 2 ng of cDNA were used as template for RT-qPCR, all as just 869 
described for 2D monolayers. 870 
 871 
Western blot 872 
Protein lysates were obtained using ice-cold 1X RIPA buffer containing protease and phosphatase 873 
inhibitors (Cell Signaling 9806), and freshly supplemented with 1 mM phenylmethylsulfonyl fluoride 874 
(PMSF). After incubation for 30 min on ice, the lysate was clarified from insoluble material by 875 
centrifugation at 16,000 g for 10 minutes at 4 °C. The protein concentration was assessed using the 876 
Pierce BCA Protein Assay Kit (ThermoFisher) according to the manufacturer’s instructions. After addition 877 
of Laemmli Sample Buffer (Bio-Rad) to a final concentration of 1x, and 2-mercaptoethanol to a final 878 
concentration of 2.5%, the samples were denatured by heating at 95 °C for 5 minutes. For electrophoretic 879 
separation, 20 µg of protein for each sample was loaded onto 7.5% Mini-PROTEAN TGX Precast Protein 880 
Gels (Bio-Rad) and run at 100V for 60 minutes using 1x Tris/Glycine/SDS running buffer (Bio-Rad). 881 
Proteins were transferred onto Immobilion-P PVDF membranes (Millipore Sigma) by means of tank 882 
blotting in 1X Tris/Glycine (Bio-Rad) supplemented with 20% methanol; transfer was performed at 100 V 883 
for 60 minutes at 4 °C. Membranes were blocked in PBS supplemented with 0.1% Tween-20 (hereafter 884 
PBST) and 4% Blotting-Grade Blocker (Bio-Rad) for 1 hr at room temperature. Primary antibody 885 
incubation of whole membranes was performed overnight at 4 °C under agitation, and antibodies were 886 
diluted in the same blocking buffer. The following antibodies were used: goat polyclonal anti-lamin A/C 887 
(Santa Cruz sc-6215), 1:500 dilution; mouse monoclonal anti-TNNI (clone OTI8H8, Novus Biologicals 888 
NBP2-46170), dilution 1:500; goat polyclonal anti-NKX2-5 (R&D Systems AF2444), dilution 1:500; goat 889 
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polyclonal anti-TBXT (R&D Systems AF2085), dilution 1:500; rabbit polyclonal anti-POU5F1 (Abcam 890 
19857), dilution 1:1000; mouse monoclonal anti-GAPDH (clone 6C5, Abcam ab8245), dilution 1:2000. 891 
Membranes were washed three times in PBST for 10 minutes at room temperature, incubated for 1 hr at 892 
room temperature with species-appropriate HRP-conjugated secondary antibodies (ThermoFisher) 893 
diluted 1:10,000 in blocking buffer, and washed three times in PBST for 10 minutes at room temperature. 894 
Chemiluminescent reaction was initiated by incubation with SuperSignal West Pico PLUS 895 
Chemiluminescent Substrate (ThermoFisher), and images were acquired using a ChemiDoc Imaging 896 
System (Bio-Rad) in “high resolution” mode. Before re-probing with a new antibody, membranes were 897 
treated with Restore Plus western blot stripping buffer (ThermoFisher), washed three times, and re-898 
blocked. Densitometric quantification of Western blots was performed using ImageJ, and protein 899 
abundance estimation was normalized on the levels of GAPDH within each lysate. 900 
 901 
RNA-seq 902 
RNA sequencing (RNA-seq) was performed on 2-3 x 106 hiPSC-CMs at day 14 of differentiation on three 903 
biological replicates (independent differentiations) per cell line. RNA-seq libraries were prepared from 904 
100 ng of total RNA (obtained as described above for RT-qPCR) using the TruSeq Stranded Total RNA 905 
LT Kit with Ribo-Zero H/M/R (all Illumina), according to the manufacturer’s instructions. The analysis 906 
RNA-seq libraries were paired-end sequenced on a Illumina NextSeq 500 in a high output run with 150 907 
cycles (75 for each end), achieving approximately 40 million paired-end reads per sample. Reads were 908 
mapped to hg38 using STAR (Dobin et al., 2013), and then quantified and processed through the 909 
Cufflinks suite (Trapnell et al., 2012), all using default parameters. Differential expressed genes exhibited 910 
a q-value < 0.05 for a pairwise comparison and were expressed at least 1 RPKM (read kilobase per 911 
million mapped reads) in one time point. Hierarchical clustering was performed with the CummeRbund 912 
suite in R. Ontology enrichment analysis was done using EnrichR (Chen et al., 2013). For comparision 913 
with previously described RNA-seq data of hESC-CM differentiation (Fields et al., 2017), all datasets 914 
were collectively re-normalized and -quantified using Cufflinks. Principal component analysis (PCA) was 915 
performed using the R function “prcomp”. 916 
 917 
In situ DNase Hi-C 918 
Genome-wide chromosome conformation capture based on in situ proximity ligation of DNase I-digested 919 
nuclei (DNase Hi-C) was performed with minor modifications of a previously described method (Ramani 920 
et al., 2016; Fields et al., 2017). The assay was performed on ~2 x 106 hiPSC-CMs at day 14 of 921 
differentiation on two biological replicates (independent differentiations) per cell line. Unless otherwise 922 
indicated, all molecular biology reagents were from ThermoFisher and reactions were performed at room 923 
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temperature (RT). Cells were fixed in the dish with fresh RPMI-1640 supplemented with 2% formaldehyde 924 
while in gentle orbital rotation for 10 min, and subsequently quenched with 25 mM Glycine for 5 min at 925 
room temperature followed by 15 min at 4 °C. Cells were then treated with 0.05% Trypsin for 10 min at 926 
37 °C, rinsed in RPMI-1640 with 10% FBS, and scraped off the plate. Cells were washed once with PBS, 927 
flash frozen in liquid nitrogen, and stored at -80 °C. After rapid thawing, samples were resuspended in 928 
500 µL of ice-cold cell lysis buffer (10 mM Tris-HCl pH 8.0, 10 mM NaCl, 0.5% Igepal CA-630, 929 
supplemented with the protease inhibitor cocktail from Sigma-Aldrich), incubated for 20 min on ice, and 930 
dounce-homogenized 60-80 times with a tight pestle. Extracted nuclei were centrifuged at 2,500 g for 1 931 
min at RT (standard spinning protocol), resuspended in 300 µL 0.5x DNase I digestion buffer with 0.2% 932 
SDS and 20 mM MnCl2, and incubated at 37 °C for 60 min with periodic gentle vortexing. Then, 300 µL 933 
0.5x DNase I digestion buffer with 2% Triton X-100, 20 mM MnCl2, and 0.4 µg/µL RNase A were added 934 
and incubated for another 10 min. Chromatin was finally digested with 7 U of DNase I during a 7 min 935 
incubation at RT. The reaction was stopped with 30 µL of 0.5M EDTA and 15 µL 10% SDS. The efficiency 936 
of DNase I digestion was confirmed by comparing the DNA shearing patterns of small samples of 937 
undigested and digested nuclei using a 6% PAGE gel (following proteinase K digestion). Nuclei were 938 
spun down and resuspended in 150 µl RNase and DNase-free water. 300 µl of AMPure XP beads 939 
(Beckman) were added to irreversibly bind nuclei; going forward nuclei were therefore cleaned up by 940 
magnetic purification. In situ reactions were performed first for end repair (15 U of T4 DNA Polymerase 941 
and 30 U of Klenow Fragment for 1 hr at RT) and dA-tailing (75 U of Klenow exo-minus for 1 hr at 37 °C), 942 
each in 200 µL, and followed by inactivation with 5 µL of 10% SDS and cleanup. Nuclei were then 943 
subjected to overnight ligation of custom T- and blunt-bridge biotin-tagged adapters (each at 8 µM; 944 
sequences detailed in Ramani et al., 2016) using 25 U of T4 DNA ligase and 5% polyethylene glycol 945 
(PEG) in a 100 µl reaction incubated at 16 °C. The reaction was stopped with 5 µL of 10% SDS, and 946 
nuclei were washed twice with AMPure buffer (20% PEG in 2.5 M NaCl) followed by 2 washes with 80% 947 
ethanol to remove un-ligated adapter. Nuclei were then treated for 1 hr at 37 °C with 100 U of T4 PNK in 948 
a 100 µL reaction to phosphorylate the adapters. Proximity ligation of DNA ends was performed for 4 949 
hours at RT using 30 U of T4 DNA ligase in a 1 mL reaction maintained in gentle agitation. Nuclei were 950 
resuspended in 1x NEBuffer 2 (New England Biolabs) with 1% SDS, and digested with 800 µg of 951 
Proteinase K overnight at 62 °C. DNA was precipitated by adding 60 µg glycogen, 50 µL 3M Na-acetate 952 
(ph5.2) and 500 µL isopropanol followed by incubation for 2 hours at -80 °C and centrifugation at 16,000 953 
g for 30 min at 4 °C. DNA was resuspended in 100 µL water and purified with 100 µL AMPure beads 954 
according to the manufacturer’s instructions, and resuspended in 100 µL elution buffer (EB; 10 mM Tris-955 
HCl pH 8.5). Biotin pull-down was performed on the purified DNA to isolate ligation products containing 956 
the biotin adapters. 100 µL Myone C1 beads were mixed with the DNA for 30 min at RT under gentle 957 
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rotation. Samples were washed 4 times with B&W buffer (5 mM Tris-HCl pH 8.0, 0.5 mM EDTA, 1 M 958 
NaCl, 0.05% Tween-20), and twice with EB. DNA was then treated on the beads to perform end-repair 959 
(200 µL reaction with the Fast DNA End Repair Kit for 10 min at 18 °C) and dA-Tailing (50 µL reaction 960 
with 25 U of Klenow exo-minus in NEBuffer 2 and 1.2 mM dATP for 30 min at 37 °C). Custom Y-adapters 961 
for Illumina sequencing (each at 2 µM; sequences detailed in Ramani et al., 2016) were then ligated 962 
using 20 U of T4 DNA ligase for 1 hour at RT in a 50 µL reaction using the Rapid Ligation Buffer. Beads 963 
were washed 4 times with B&W buffer and twice with EB after each of these reactions. Finally, libraries 964 
were amplified by 12 PCR cycles with Kapa HiFi ReadyStart Master Mix with custom barcode-containing 965 
primers (sequences detailed in Ramani et al., 2016). Libraries were purified with 0.8x Ampure XP beads 966 
according to the manufacturer’s instructions, quantified with a Qubit and the DNA high-sensitivity reagent, 967 
and pooled at equimolar ratios in preparation for next-generation sequencing. Samples were paired-end 968 
sequenced on three runs with an Illumina NextSeq 500 at high output with 150 cycles (75 for each end), 969 
resulting in approximately 150 M paired-end reads per sample. 970 
 971 
Hi-C data analysis 972 
Fastq files were mapped to the hg38 genome using BWA-MEM with default parameters, mapping each 973 
end of the read pairs individually. The mapped files were processed through HiC-Pro (Servant et al., 974 
2015), filtering for MAPQ score greater than 30 and excluding pairs less than 1 Kb apart, to generate 975 
valid pairs and ICE balanced matrices at 500 Kb resolution. Hi-C QC metrics from HiC-Pro are reported 976 
in Supplemental Table 3. Samples were clustered based on HiC-Rep scores calculated using a resolution 977 
of 500 Kb with a max distance of 5 Mb and h = 1 (Yang et al., 2017). Hi-C contact matrix heatmaps for 978 
cis or trans interactions were generated with Cooler (https://github.com/mirnylab/cooler) using default 979 
parameters and logarithmic interaction probabilities, without diagonals. A/B compartmentalization was 980 
computed by eigenvalue decomposition of the contact maps using HOMER (Heinz et al., 2010) with 500 981 
Kb resolution and no additional windowing (super-resolution also set at 500 Kb). The sign of the first 982 
eigenvector (PC1) was selected based on the expression ~5000 genes constitutively expressed across 983 
hESC-CM differentiation (Fields et al., 2017), so that positive and negative values indicate A and B 984 
compartmentalization, respectively. Saddle plots of inter-compartment interaction enrichment were 985 
generated by assigning each genomic bin to its corresponding percentile value based on PC1, and 986 
dividing the genome into 10 deciles. Each interaction was normalized to the average score at the 987 
corresponding distance (for cis interactions) or to the average of all contacts (for trans interactions), and 988 
assigned to a pair of deciles based on the PC1 scores of the two bins. The data was plotted in heatmaps 989 
representing the log2 average value for pairs of deciles, while the change between mutant and corrected 990 
hiPSC-CMs is the log2 value of the difference in such values. To calculate the interaction probability at 991 
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varying genomic distances based on compartmentalization, each interaction was assigned to A-A, B-B, 992 
or A-B based on the pairs of bins involved, and then the average interaction score for a given distance 993 
was normalized to the average interaction score for all pairs of contacts at that distance. The data was 994 
plotted on a logarithmic scale and loess-smoothed using the R function “geom_smooth”. Visualization of 995 
sample similarity by PC1 scores was performed with the R function “prcomp”. Gene tracks were 996 
generated using IGV (Thorvaldsdóttir et al., 2013). Changes in A/B compartmentalization were 997 
determined by a one-way ANOVA of PC1 scores across the two replicates for the three cell lines, using 998 
a significance cutoff of p-value < 0.05 combined by the need for the average PC1 to change sign across 999 
at least one pair of condition. Consistent changes in A/B compartmentalization were further selected if 1000 
the average PC1 score for mutant hiPSC-CMs changed sign compared the average PC1 score of each 1001 
corrected hiPSC-CMs. 1002 
 1003 
Statistical analyses 1004 
Unless specifically described elsewhere in the methods, all statistical analyses were performed using 1005 
Prism 7 (GraphPad). The type and number of replicates, the statistics plotted, the statistical test used, 1006 
and the test results are described in the figure legends. All statistical tests employed were two-tailed. No 1007 
experimental samples were excluded from the statistical analyses. Sample size was not pre-determined 1008 
through power calculations, and no randomization or investigator blinding approaches were implemented 1009 
during the experiments and data analyses. When a representative experiment is reported, this 1010 
exemplifies the results obtained in at least two independent biological replications. 1011 
 1012 
Data and code availability 1013 
Hi-C and RNA-seq data is available on Gene Expression Omnibus accession number GSE126460. 1014 
Custom code for Hi-C analyses was previously described (Fields et al., 2017) and is available on github 1015 
(https://github.com/pfields8/Fields_et_al_2018/). All other raw data and custom code is available from 1016 
the corresponding author upon reasonable request. 1017 
 1018 
Supplemental material 1019 
The Supplemental material linked to this article includes Supplemental Figures 1 to 4 and their matching 1020 
Figure Legends (presented in the same document), Supplemental Tables 1 to 5 (presented as individual 1021 
files), Supplemental Tables 6 and 7 (presented in the same document as the Supplemental Figures), and 1022 
Supplemental Videos 1 to 8 (presented as individual files).  1023 
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Abbreviations 1404 
3D-EHT(s): three-dimensional engineered heart tissue(s) 1405 
A/B: active/inactive (chromatin compartment) 1406 
CCQ: contraction correlation quantification 1407 
FPD: field potential duration 1408 
DCM: dilated cardiomyopathy 1409 
Hi-C: genome-wide chromosome conformation capture 1410 
hESC(s): human embryonic stem cell(s) 1411 
hESC-CM(s): human embryonic stem cell-derived cardiomyocyte(s) 1412 
hiPSC(s): human induced pluripotent stem cell(s) 1413 
hiPSC-CM(s): human induced pluripotent stem cell-derived cardiomyocyte(s) 1414 
LAD(s): lamin-associated domains 1415 
MEA(s): multi-electrode array(s) 1416 
PC: principal component 1417 
RNA-seq: ribonucleic acid sequencing 1418 
RT-qPCR: quantitative reverse transcription polymerase chain reaction 1419 
TAD(s): topologically associating domain(s)  1420 
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Figures and figure legends 1421
 1422
Figure 1. Generation of lamin A/C haploinsufficient hiPSC-CMs. 1423
(A) Predicted effect of the LMNA R225X mutation on the two splicing products lamin A and C. Key protein domains 1424
and their location along the amino acid sequence are indicated. (B) Sanger sequencing of LMNA exon 4 in hiPSCs 1425
with heterozygous R225X mutation (top), or in hiPSCs obtained after CRISPR/Cas9-based scarless correction of 1426 
the mutation (bottom). (C) Schematic of the protocol for step-wise directed differentiation of hiPSC-CMs. CHIR: 1427 
CHIR99021 (WNT activator); WNT C-59: WNT inhibitor; AA: ascorbic acid. (D) Quantification of cardiac 1428 
differentiation efficiency by flow cytometry for cardiac troponin T (TNNT2) on hiPSC-CMs at day 14 of differentiation.1429 
The percentage of TNNT2+ cells is reported. (E) RT-qPCR analyses at the indicated stages of hiPSC-CM 1430 
differentiation (see panel C). Differences versus mutant were calculated by two-way ANOVA with post-hoc Holm-1431 
Sidak binary comparisons (* = p < 0.05, *** = p < 0.001; n = 3 differentiations; average ± SEM). (F) Representative 1432 
western blot for lamin A/C and differentiation markers during iPSC-CM differentiation. (G) Quantification of lamin 1433 























































LMNA isoform A LMNA isoform C
































































































Day 0 Day 2 Day 4 Day 6 Day 14
CHIR WNT C-59
RPMI + B27.RPMI + AA + BSA
Mutant Corrected 1 Corrected 2Isotype control














82 244 350 644572
not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 
The copyright holder for this preprint (which wasthis version posted February 19, 2019. ; https://doi.org/10.1101/555250doi: bioRxiv preprint 
 41 
versus mutant were calculated by one-way ANOVA with post-hoc Holm-Sidak binary comparisons (** = p < 0.01,  1435 
*** = p < 0.001; n = 3 differentiations; average ± SEM). Throughout the figure (and in all other figures), Mut or Mutant 1436 
indicates LMNA R225X hiPSCs, and Corr.1/2 or Corrected 1/2 indicate the two isogenic corrected control LMNA 1437 
R225R hiPSC lines.  1438 
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 1439 
Figure 2. Electrophysiological properties of lamin A/C haploinsufficient hiPSC-CMs. 1440 
(A) Representative traces from MEA recordings of spontaneous electrical activity in hiPSC-CM monolayers. On the 1441 
right, the average field potential changes during an individual beat are reported, and depolarization and 1442 
repolarization timings are indicated by vertical lines. (B) Representative quantifications of electrophysiological 1443 
properties from MEA analyses. Differences versus mutant were calculated by one-way ANOVA with post-hoc Holm-1444 
Sidak binary comparisons (** = p < 0.01, *** = p < 0.001; n = 5-16 wells; average ± SEM). (C) Representative 1445 
voltage recordings by whole-cell patch clamp during evoked action potentials in individual hiPSC-CMs. (D) 1446 
Quantifications of electrophysiological properties from whole-cell patch clamp analyses. Differences versus mutant 1447 
were calculated by one-way ANOVA with post-hoc Holm-Sidak binary comparisons (* = p < 0.05, ** = p < 0.01, *** 1448 
= p < 0.001; n = 26-30 cells from two differentiations; average ± SEM). (E) Representative optical recordings of 1449 
calcium fluxes with Fluo-4 in hiPSC-CM monolayers electrically paced at 1 Hz. (F) Representative quantifications 1450 
of calcium fluxes properties. Differences versus mutant were calculated by unpaired t-test (*** = p < 0.001; n = 69-1451 
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 1453 
Figure 3. Contractile properties of lamin A/C haploinsufficient hiPSC-CMs. 1454 
(A) Representative measurements of cellular displacement during contraction of hiPSC-CM monolayers electrically 1455 
paced at 1 Hz. (B) Representative quantifications of cell contractility from analyses of optical recordings. Differences 1456 
versus mutant were calculated by one-way ANOVA with post-hoc Holm-Sidak binary comparisons (* = p < 0.05; n 1457 
= 5-6 field of views; average ± SEM). (C) Representative measurements of twitch force during contraction of 3D-1458 
EHTs electrically paced at 1 Hz. (D) Representative quantifications of tissue contractility from analyses of optical 1459 
recordings. Differences versus mutant were calculated by one-way ANOVA with post-hoc Holm-Sidak binary 1460 
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 1462
Figure 4. Gene expression changes in lamin A/C haploinsufficient hiPSC-CMs. 1463
(A) RT-qPCR analyses in hiPSC-CMs at day 14 of differentiation. Differences versus mutant were calculated by 1464
one-way ANOVA with post-hoc Holm-Sidak binary comparisons (* = p < 0.05, n = 3 differentiations; average ± 1465
SEM). (B) Hierarchical clustering of hiPSC-CMs analyzed by RNA-seq based on all expressed genes. Biological 1466
replicates from 3 independent differentiations were analyzed (r1, r2, r3). (C) Overlap in genes up- or downregulated 1467 
in mutant hiPSC-CMs versus hiPSC-CMs from the two corrected control lines (fold-change > 2 and q-value < 0.05; 1468 
Table S1). (D) Selected results from ontology and pathway enrichment analyses of genes consistently up- or 1469 
downregulation in mutant hiPSC-CMs. For each term, the rank and the corresponding p-value are reported (terms 1470 
ranked by combined score; Table S2). (E) Linear dimensionality reduction by principal component analysis of RNA-1471 
seq data of mutant and corrected hiPSC-CMs, and hESC-CMs sampled at different time points of differentiation 1472 
(Fields et al., 2017). The amount of variance captured by each of the two main principal components (PC) is 1473 
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 1475
Figure 5. Global properties of chromatin topology in lamin A/C haploinsufficient hiPSC-CMs. 1476
(A) Hierarchical clustering of hiPSC-CMs analyzed by in situ DNase Hi-C based on similarity scores between the 1477
genomic contact matrices calculated with HiCRep. Biological replicates from 2 independent differentiations were 1478
analyzed (r1, r2). (B) Proportion of genomic interactions between different chromosomes (trans) or within the same 1479
chromosome (cis) involving distances < 20 Kb (cis short) or > 20 Kb (cis long; Table S3). Differences versus mutant 1480 
were calculated by two-way ANOVA with post-hoc Holm-Sidak binary comparisons (* = p < 0.05; n = 2 1481 
differentiations; average ± SEM). (C) Representative heatmaps of differential contact matrices between 1482 
chromosomes. Autosomes are ranked based on their size from left to right and top to bottom. (D) Representative 1483 
heatmaps of differential cis interactions between active (A) and inactive (B) chromatin compartments. 500 Kb 1484 
genomic bins were assigned to ten deciles based on their PC1 score from the linear dimensionality reduction of the 1485 
Hi-C matrix (from most B to most A; Table S4), and average observed/expected distance normalized scores for 1486 
each pair of deciles were calculated. (E) Probability of cis genomic contacts over increasing genomic distance for 1487 
regions in homotypic (A-A or B-B) or heterotypic (A-B) chromatin compartments. Values are normalized to all 1488 
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 1490 
Figure 6. Chromatin compartment transitions in lamin A/C haploinsufficient hiPSC-CMs. 1491 
(A) Heatmap of all significantly different A/B compartment scores (Hi-C matrix PC1; p < 0.05 by one-way ANOVA; 1492 
n = 2 differentiations; Table S4) in 500 Kb bins that changed PC1 sign between two or more conditions. Positive 1493 
and negative PC1 indicate A and B compartmentalization, respectively. (B) Representative log-transformed contact 1494 
probability maps for chromosome 19. Topologically associating domains (TADs) are visible as squares along the 1495 
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patterns. Two genomic regions which show different compartmentalization in mutant hiPSC-CMs are indicated by 1497 
dashed boxes to highlight the differences in contact probabilities with other genomic regions off the diagonal. (C) 1498 
Linear dimensionality reduction by principal component analysis of A/B compartment scores from Hi-C data of 1499 
mutant and corrected hiPSC-CMs, and hESC-CMs sampled at different time points of differentiation (Fields et al., 1500 
2017). The amount of variance captured by each of the two main principal components (PC) is reported, and the 1501 
biological interpretation for the PC1 axis is indicated. (D) Significance of the overlap between changes in A/B 1502 
compartments in mutant hiPSC-CMs and those occourring during hESC-CM differentiation. The number of genomic 1503 
bins within each of the categories is indicated, and p-values were calculated by chi-squared tests. Note that only 1504 
autosomes were considered. (E) Representative genomic tracks of chromatin compartmentalization for 1505 
chromosome 19 and a section of chromosome 5. Positive and negative Hi-C matrix PC1 scores are shown in red 1506 
and blue, and indicate 500 Kb genomic bins in the A and B compartments, respectively. Genomic regions that 1507 
transition from A to B during hESC-CM differentiation but remain in A in mutant hiPSC-CMs (noted as B to A) are 1508 
indicated by dashed boxes. Selected genes found within such regions are listed (refer to Fig. 7 and Fig. S4).  1509 
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 1510
Figure 7. Correlation between altered chromatin compartmentalization and gene expression changes in 1511
lamin A/C haploinsufficient hiPSC-CMs. 1512
(A) Violin plots showing the expression of genes found with lamin A/C-sensitive domains (average expression in 1513
RNA-seq data from 3 differentiations). Boxplots indicate the first quartile, median, and third quartile, while whiskers 1514
are from the 5th to 95th percentile. In the left panel, note that the tail of genes expressed at very low levels in corrected 1515 
hiPSC-CMs is less pronounced in mutant cells. (B) Selected results from ontology enrichment analyses of 1516 
upregulated genes in domains aberrantly found in the A compartment in mutant hiPSC-CMs (average fold-change 1517 
> 2; Fig. S3C). Term as are listed by their rank based on the combined score, and the p-values are reported (Table 1518 
S5). (C-D) RT-qPCR validation of gene expression changes in hiPSC-CMs matured by culture in vitro for 30 days 1519 
(C) or by generation of 3D-EHTs (D). Differences versus mutant were calculated by one-way ANOVA with post-hoc 1520 
Holm-Sidak binary comparisons (* = p < 0.05, ** = p < 0.01; n = 4 differentiations for panel C, and n = 3 3D-EHT 1521 
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 1523
Figure 8. Role of P/Q- and L-type calcium currents in electrophysiological abnormalities of lamin A/C1524
haploinsufficient hiPSC-CMs. 1525
(A-B) Representative quantifications of electrophysiological properties from MEA analyses. hiPSC-CMs were 1526
maintained in standard culture conditions, or pre-treated for 20 min with the indicated inhibitors for P/Q-type calcium 1527
channels (ω-Conotoxin MVIIC: 2 µM; ω-Agatoxin TK: 0.5 µM). Differences versus mutant were calculated by one-1528 
way ANOVA with post-hoc Holm-Sidak binary comparisons (* = p < 0.05, n = 3-8 wells; average ± SEM). (C-D) RT-1529 
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generation of 3D-EHTs (D). Differences versus mutant were calculated by one-way ANOVA with post-hoc Holm-1531 
Sidak binary comparisons (* = p < 0.05, ** = p < 0.01, *** = p < 0.001; n = 4 differentiations for panel C, and n = 3 1532 
3D-EHT batches for panel D; average ± SEM). (E) As in panels A-B, but hiPSC cm were pre-treated for 10 min with 1533 
increasing doses of the L-type calcium channel blocker verapamil. (F) Proposed model for the chromatin 1534 
compartmentalization-dependent and independent effects of lamin A/C haploinsufficieny in developing hiPSC-CMs. 1535 
Mutant cells have stronger interactions within the A compartment and decreased intermixing of A and B 1536 
compartments. Trans interactions are globally reduced, while large chromosomes (exemplified by chromosomes 5 1537 
and 12) and small-chromosomes (exemplified by chromosome 19) self-associate more. Compartmentalization of 1538 
selected genomic hotspots is dysregulated, in particular for compartments that developmentally transition from A to 1539 
B in normal hiPSC-CMs but remain in A in mutant cells (exemplified by the magenta, green, and yellow loci). A 1540 
large number of genes are dysregulated independently of chromatin compartment changes (exemplified by the red 1541 
locus). These combined effects drive stronger L-type calcium currents (thick red line) and ectopic P/Q type calcium 1542 
currents (thin magenta line), leading to prolonged action potentials, stronger calcium fluxes, systolic hyperfunction, 1543 
and diastolic dysfunction. 1544 
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